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ABSTRACT 
A primary biosafety issue of retroviral vector-mediated gene therapy is the genetic 
instability of retroviral vectors. Reverse transcription of vector RNA genome is initiated by 
viral reverse transcriptase (RT) in a virion particle after infection of a target celi. During 
reverse transcription, abnormal template switches between vector and occasionally co-
packaged helper virus in a virion particle can therefore enable helper virus to regain 
replication elements from the vector and revert to replication-competent retrovirus (RCR). 
This research was undertaken to study the origins of RT enzyme activities and test the 
hypothesis that RT enzyme activities are contributed by both exogenous RT, which is 
imported by the re-infection of vector virions, and endogenous RT, which is provided by 
Intracellular vector virion particles. Superinfection of vector in vector producer cells (VPC) 
can increase the number of integrated vectors in VPC, and is mainly caused by decreased 
Env-receptor interference, a consequence of helper virus gene inactivation by host DNA 
methylation at the 5' LTR promoter region. Suppression of helper virus gene expression by 
DNA methylation also reduces vector production. A chimeric retroviral helper virus 
combined with picomavirus IRES (internal ribosome entry site) sequence and a selection 
marker was therefore constructed to eliminate DNA methylated helper virus from cell 
populations to maintain active gene expression and enhance Env-receptor interference. 
Packaging cells established by this chimeric helper virus exhibit high titer production without 
detectable superinfection. In addition to exogenous RT activities imported by superinfection, 
significant endogenous RT activities (0.2% to 7.8% of exogenous RT activity), which 
originates from viral precursor protein PrlSO^®^"'*", were also demonstrated by intracellular 
retrotransposition of a retroviral vector in VPC. Retrotransposed vectors can integrate into 
different chromosomal locations to increase the plasticity of the VPC genome as observed 
ix 
from superinfected vectors. The outcomes from this study provide important Insights for 
further strategies designed to prevent RCR formation by inactivation of RT activity. 
Demonstration of Intracellular retrotransposition of retroviral vectors in VPC may reveal an 
alternative replication pathway of retrovirus. 
1 
CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
The use of retroviral vector in gene therapy. Moloney murine leukemia viais-
(MoMLV) based retroviral vectors are being used in 71% of the protocols approved by the 
U. S. Recombinant DNA Advisory Committee (23). Permanent modification of a targeted 
cell's genotype by the integration of retroviral vector genetic information (28) and the 
consistent production of retroviral vectors from permanent packaging cells without helper 
virus (4, 25) are the most significant advantages of retroviral vector systems over other viral 
vectors. The stable integration of transferred genes is an attractive feature that may permit 
treatment of hereditary and chronic disorders, although it may potentially result in insertional 
mutagenesis and oncogenesis (10, 35, 38). The reproducibility of therapeutic retroviral 
vector production from a stable VPC is very important for safety and quality assurance 
when conducting clinical trials on human subjects (41). 
Overview of retroviral vector packaging systems. MoMLV is a RNA retrovirus 
that packages two copies of retroviral genomic transcripts associated with cellular tRNA 
primers and essential viral replication components, such as protease, RT and integrase 
(IN), into its virion particles (Figure 1A). The packaging signal, T, and the redundant 
sequences termed long terminal repeats (LTR), which flank both the 5' and 3' ends of 
genomic transcripts, are essential for the packaging and reverse transcription of viral RNA 
transcripts during replication (3). Currently applied retroviral vector systems contain two 
basic components (Figure 1B): the retroviral vector itself, which contains ^ signal and LTR 
but does not encode any viral proteins, and the helper virus, which provides gag, pol and 
env gene products in trans for retroviral vector assembly and transfer (28). The T signal 
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FIG. 1. Retrovirus-mediated gene transfer. (A) Scheme of retrovirus. (B) Helper virus and 
vector. (C) Gene delivery of retroviral vector. 
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and 3' LTR of the helper virus can be deleted to prevent the helper virus RNA transcripts 
fironn being packaged and subsequently reverse transcribed during the production of the 
recombinant retroviral vectors (25, 27). 
Production problems with retroviral vector. A major consideration for the safety 
of retrovirus vector application is the detection and elimination of RCR in the vector 
preparations, although murine MoMLV based vector was not considered as an acute 
pathogen for primates (5). Recently, Donahue et al. (8) reported that 3 of 10 rhesus 
monkeys developed T cell lymphoma after receiving bone marrow transplants which were 
transduced with RCR-contaminated MoMLV-based retroviral vector. None of the analyzed 
lymphoma cells carried vector sequences, but they all contained multiple copies of RCR. 
In addition to the T cell lymphoma, the infection of wild type MLV, which is replication 
competent (e.g. RCR), can also cause abnormal T cell proliferation and result in leukemia 
(37). This kind of T cell proliferation is possibly induced by the binding of retrovirus to the 
receptors on T cells (11), Integration of a viral promoter into the host genome resulting in 
the overexpression of proto-oncogenes (18, 38) or a complex chromosome rearrangement 
(14). Since RCR can also replicate in the target cells, such as the primate T cells described 
above, RCR can also cause acute viremia without activating any cellular oncogenes by 
genetic recombination (13). The formation of RCR has been demonstrated to occur by the 
abnormal template switches between helper virus and retroviral vector sequences during 
reverse transcription (Figure 2). 
Retroviral RT enzyme intends to 'jump' from one template to the other during 
reverse transcription of RNA genome. Indeed, this 'jumping' feature is essential for 
retrovirus replication while the 5' LTR region Is reverse transcribed into DNA and serves as 
a primer to polymerize first strand DNA started from 3' LTR. This primer jumping is needed 
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FIG.2. Reverse transcription and recombination. (A) Reverse transcription. (B) Template 
switchings between helper virus and vector transcripts enable helper virus to regain 
replication elements for replication-competent retrovirus (RCR) formation. 
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again while second strand DNA is initiated by a poiypurine tract (ppt) as a primer at 3' LTR 
and then jumps onto 5' LTR to complete double-stranded provirus followed by integration. 
Once a helper virus is co-packaged into a virion particle with vector, the nature of RT 
enzyme enables the helper virus to pick up essential sequences from vector transcript to 
regain its replication ability by switching templates between helper virus and vector. 
Compared to helper virus which contains gag, pol and env in one transcript, a more 
advanced helper virus has been developed by separating the env gene from the gag-pol 
genes. This is in an attempt to reduce the probability of RCR formation, since at least three 
recombination events are required before RCR can be produced (22). However, RCR 
outbreaks still occur in these 'split-function' packaging cells (2). Therefore, the prevention of 
RCR outbreak from VPC in the future may require attempts to block or decrease RT 
enzyme activities inside of VPC instead of simply separating helper virus genes. 
The phenotype of VPC can be altered by insertional mutagenesis of proviral vector 
re-integration. In some gene therapy clinical trials, VPC have been implanted into tumor 
lesions in the brain (30) and intraperitoneal cavity (20) of human subjects, therefore, the 
stability of VPC genotypes is a biosafety concem for gene therapy with this approach. 
Possible origins of RT enzyme activity. Within VPC, there are two possible 
categories of RT enzyme activity: 1) exogenous viral RT. which is brought into the cell by 
virus infection. In cultured VPC, the only source of exogenous RT enzyme activity would be 
derived from the re-infection of vector virions; 2) endogenous RT. which is the combined RT 
enzyme activity of the helper virus-encoded PrlSO^^^"'"'or po/gene product of virion particles 
within the cell (6, 17, 33, 45), endogenous retroviruses (9, 19) and retrotransposons (12, 15, 
16). These different sources of endogenous RT enzyme activity can result in intracellular 
retrotransposition activity (Figure 3) (for review see reference 21). 
6 
Integration 
cDNA 
Reverse Transcription 
AAA Spliced mRNA Translaton 
cDNA Integration 
Reverse Transcription 
• • 
Proteins 
(Gag) 
•AAA Translation 
mRNA 
cDNA 
Reverse Transcription 
Proteins 
• • 
• .• Budding 
Translation AAA 
No Reinfection 
mRNA 
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During the vector assembly process, viral Env protein produced by the helper virus is 
transported to the cell membrane where it binds the cellular receptor used for virus entry 
(24, 43, 49). This Env-receptor interference can dramatically reduce the re-infection of 
vector virions for imported exogenous RT (Figure 4). The re-infection ratio of amphotropic 
MoMLV (Am-MoMLV) vector virion on target cells, which were previously infected with wild 
type Am-MoMLV, is as low as 1 x 10"^ events per cell (26). 
In contrast, intracellular retrotransposition of an Env-defective C-type MoMLV can 
occur at a higher frequency of 2.7 x 10"* events per cell on feline G355-5 cells which are not 
susceptible to MoMLV infection (Figure 5). The endogenous RT enzyme activity required for 
retrotransposition originated from intracellular particles of gag-pol gene products (46). Un-
cleaved PrlSO^^ '^has been demonstrated with 30% to 50% of RT enzyme activity 
compared to cleaved, matured RT in virion particle (6, 17, 33). In turn, the core proteins of 
virion particles inside host cells without the maturing process, which usually involved 
cleavage of Gag and Pr180^ '^, can initiate reverse transcription without a budding process 
and is the major portion of endogenous RT activity in a retrovirus infected cell (45, 46). 
Consequences of RT enzyme activity inside cells. The RT enzyme activity in a 
cell will produce more proviral vector (cDNA) by reverse transcription and possibly increase 
integrations into the host genome. Approximately, 10% of the human genome is estimated 
to consist of reverse transcribed and transposed sequences (1). These abundant 
endogenous RT activities can be reproduced in experimental systems. Episomal proviral 
DNA, the product of the reverse transcription reaction during retrotransposition process, has 
been estimated as one copy (event) per 10"* cells from LINE retrotransposition (39). 
Integration of proviral DNA can result in deletion (15) or inactivation (44) of targeted DNA, 
8 
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FIG. 4. Env-receptor interference and superinfection of vectors on vector producer cells. 
Resistance to superinfection of vector depends on threshold gene expression of helper virus 
(Chapter 3). 
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FIG. 5. Intracellular retrotransposition of an Env-defective Moloney murine leukemia virus. 
Note that an Env-defective viral particle is non-infectious and, therefore no superinfection 
occurs. 
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greater genome fluidity (29, 36, 48), as well as in the genesis of functional genes (42)(for a 
review see reference 34). 
In gene transfer studies, exogenous RT imported by retrovirus infection is correlated 
with a risk of RCR formation which is initiated by template switches between co-packaged 
helper virus and vector transcripts during reverse transcription. The recombination feature 
of reverse transcription also enables retroviruses to modulate their genome to survive under 
artificial or natural selection pressure. In a single retroviral replication cycle, approximately 
8.8% of herpes simplexvirus thymidine kinase (HStk) genes in MoMLV-based vectors can 
be deleted when transduced cells are placed under the selection pressure (e.g. neomycin 
analog, G418) for another selectable gene (neomycin phosphotransferase, neo") present in 
the vector (31, 47). This represents a mutation rate of 3% per kb per retroviral replication 
cycle (31). 
Stability of integrated provirus. Once a provirus integrates into a host genome, 
this integrated provirus becomes part of host genome and can replicate with host 
chromosomal replication during mitosis. Integration of provirus has been generally 
considered very stable and can be transmitted from one generation to the next if a provirus 
integrates into gamete cells. A previous study has only shown a mutation (deletion) rate of 
integrated provirus as low as 4.5 x 10"® events per gamete by studying mouse coat color 
revertants. The deletion of this provirus in the mouse genome was hypothesized to occur by 
homologous recombination between the two LTR and deletion of the provirus to restore the 
dilute (d'O allele (40). In this study, a deletion of provirus integration site was observed in 
one of six subclones of LTKOSN.2 VPC (Chapter 3), which is significantly higher than 
above mentioned deletion rates. Several mechanisms have been considered for the 
instability of integrated provirus. One proposal is an auto-integration process in which 
11 
proviral vector integrates into a previously-integrated provirai vector. This has been 
observed in a complex episomal provirus of human immunodeficiency virus (HIV) (32). A 
translocation or amplification mechanism of a cellular gene allele by unequal sister-
chromatid exchange or disproportionate replication (for review see reference 37) may also 
be involved. 
Dissertation Organization 
The work described in this dissertation has focused on the study of genetic instability 
of retroviral sequences and the host genome caused by host-virus interactions. Because of 
the insertion of an antibiotic selection marker gene in retroviral vector construct, this 
selection marker gene becomes a useful DNA marker to distinguish retroviral vector 
sequences from endogenous retroviral elements. Therefore, one can study the evolution of 
viral sequences in the host cell during retrovirus replication. A VPC designed for gene 
transfer purposes is an excellent model to represent a retrovirus-infected cell for studying 
the host-retrovirus interaction on genetic stability of both retroviral sequences and host 
genome. The first manuscript, "Restriction mapping of retroviral vector mutation by 
analyzing episomal DNA", describes the details of a deletion of a theraputic gene from a 
retroviral vector. The finding of this second vector in our VPC initially led to the study of 
genetic instability of VPC in this dissertation. This manuscript will be submitted to 
Biotechniques. The second manuscript, "DNA methylation increases genetic instability of 
retroviral vector producer cells", describes cascade reactions initiated by DNA methylation 
of retroviral helper virus. The consequences are genome fluidity of host cells and decreased 
vector production. This manuscript will be submitted to the Journal of Virology. The third 
manuscript, "Chimeric retroviral helper virus and picornavirus IRES sequence to eliminate 
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DNA methylation for improved retroviral packaging ceils", is to confirm the role of de novo 
DNA methylation involved in host-virus interaction and describes an innovation designed to 
Improve retroviral vector production for gene transfer study. This manuscript will be 
submitted to Human Gene Therapy \o support the previous manuscript. The last 
manuscript, "High frequency retrotransposition of retroviral vectors in cultured vector 
producer cells", is using a retroviral vector system to demonstrate abundant 
retrotransposition activities of vector in VPC. Results from this study also reveal an 
alternative replication pathway of exogenous retrovirus in addition to well studied cell-to-cell 
transmission pathway of retrovirus replication. This manuscript will be submitted to Human 
Gene Therapy as well. Following the manuscripts is a "general conclusions" section to 
describe further studies and possible tasks to prevent genetic instability in VPC. Appendix A 
is an application of chimeric retroviral helper virus to establish a human packaging ceil 
population to evade human immune surveillance /n vitro. 
Won-BIn Young was the principal investigator on the research reported in each of 
the manuscripts and Appendix, and was the first author of the manuscripts. The work in this 
dissertation was advised by co-major professors Gary L. Lindberg and Charies J. Link, Jr. 
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INTRODUCTION 
The Infidelity of RT enzyme activity during the replication cycle of retrovirus can 
cause retroviruses to rapidly mutate and this raises several biosafety issues, such as 
deletion of therapeutic gene from vector and replication-competent retrovirus (RCR). In a 
single retroviral replication cycle, a therapeutic herpes simplex virus (HSV) thymidine kinase 
(tk) gene was inactivated in approximately 8% of Moloney murine leukemia virus (MoMLV) -
based vectors and mutation rates within a single retroviral vector were calculated as high as 
3% per kb (7, 12). In addition to the deletion of HSVtk from retroviral vector, retroviral 
vectors carrying nerve growth factor receptor gene (5), a-rev sequence (1), or human 
glucocerebrosidase (14), have also been observed with a deletion mutation. To distinguish 
mutant vector from primary vector from genomic DNA is difficult since both vectors share 
most of the DNA sequences except the deletion region. To characterize the primary 
structure of deletion mutated vector and define the deletion region requires several probings 
on Southern blot analysis for restriction endonuclease mapping, which is easily interfered by 
endogenous retroviral element sequences in the mammalian genome, since these 
sequences are highly homologous to vector sequences. 
High frequency of superinfection (15) and retrotransposltion activity (16) of retroviral 
vector in cultured VPC results in a detectable amount of episomal DNA which is suitable for 
Southern blotting analysis of mutated vector without the above mentioned complications. 
The observations of episomal vector or retroviral sequences were also previously reported 
with other retroviruses, including mouse mammary tumor virus (9), avian sarcoma virus (13), 
avian leukosis virus (10), HIV-1 (8) and in avian packaging cells (4). In this study, we 
successfully identified a HSVtk-deleted vector from VPC by analyzing episomal DNA instead 
of complicated genomic DNA restriction mapping. 
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MATERIALS AND METHODS 
Construction of the pLTKOSN retroviral vector and LTKOSN.2 vector producer 
cell line. The pLTKOSN plasmid DNA (kindly provided by J. P. Levy) was constructed in a 
LXSN retroviral backbone (kindly provided by A. D. Miller) and has been designed to 
express both the neo"^ and HStk gene (6). The HStk open reading frame was amplified with 
the upstream primer 5'CCA AGC TTC GGC CAG CGC CTT GTA G 3' (25 mer) and 
downstream primer 5'CCA AGC TTC CGG TAT TGT CTC CTT CC3' (26 mer). The HStk 
gene was ligated into the PCR cloning vector, PCR II (Invitrogen, Carlsbad, CA), to produce 
pTKO-PCRII which contains EcoR I sites flanking the TKO PCR product A 1,201 bp TKO 
EcoR I fragment from pTKO-PCR II was isolated and cloned into the EcoR I (X) site of 
pLXSN to produce pLTKOSN (Fig. 1A). 
LTKOSN.2 VPC was established by transient transfection of pLTKOSN plasmid DNA 
into the ecotropic packaging cell line GP+E86 (kindly provided by A. Bank). Supemates from 
these cells were used to transduce the amphotropic retroviral packaging line PA317 (kindly 
provided by A. D. Miller) and selected in G418 (1 mg/ml) for 2 weeks. Twenty different VPC 
clones were subcloned from the original pool. LTKOSN.2 VPC produces a high titer of 
approximately 1 x 10® colony formation unit (cfu) per ml by G418 selection on transduced 
target cells (3). 
RNA analysis of LTKOSN vector supernatants. Viral supernatant was subjected 
to 20% sucrose gradient ultracentrifugation (125,000 X g) for 2hr at 4°C for virion pelleting 
and then extracted by RNAzol (Biotecx, Houston, TX). Viral RNA was subjected to Northern 
blot analysis on a 1% agarose-0.4M formaldehyde gel. Vector transcripts were detected by 
Neo''probe and HStk probe. 
Episomal DNA analysis. Episomal DNA was extracted from the cytoplasmic fraction 
of 1 X 10^ LTKOSN.2 VPC. Briefly, cells were trypsinized and subjected to 1% Triton X-100 
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detergent for 5 min at room temperature to lyse only the cellular membrane but not nuclear 
membrane. Nuclei were separated from the cytoplasmic fraction by centrifugation at 9,500 X 
g for 5 min at 4°C (2). Cytoplasmic fractions were subjected to phenol/chloroform extraction 
(11). These episomal DNA samples were treated with ribonuclease A (RNase A, 1 mg/ml, 
Boehringer Mannheim, Indianapolis, IN) to eliminate RNA contamination prior to restriction 
enzyme digestion. Southern blot analysis of episomal proviral LTKOSN and ALTKOSN DNA 
was performed and the membrane was hybridized with various probes, Including long 
terminal repeat (LTR; SacW/Kpnl), extended packaging signal sequence SpeUEcoRl), 
HSVtk (EcoRl fragment), SV40 promoter (BamHUStul), and Neo*" {Hind\\\/Bpm\), 
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respectively (Fig. 1 A). These probes were labeled with P-dCTP by a random primer 
method according to the manufacturer's protocol (Boehringer Mannheim). 
DNA ampiification and sequence analysis of ALTKOSN. To analyze the deletion 
region of ALTKOSN proviral vector, genomic DNA was PGR amplified by forward primer, 5'-
CTG TGT CTG TCC GAT TGT CTA GTG TC-S within the extended packaging 
signal region, and reverse primer, 5'-CCC TTC CCG CTT CAG TGA CAA CG-3' within the 
Neo'" gene. The PGR product was purified by gel separation and subjected to sequencing 
analysis (DNA Sequencing Facility, Iowa State University, Ames, Iowa) by using the same 
primers. 
RESULTS 
A deletion of the HStk gene in our vector production was first detected in viral RNA 
collected from pelleted viral particles in Northem blot analysis by using different probes (Fig. 
1). To avoid the detection of endogenous retroviral elements and helper virus present In the 
cellular genomes, unintegrated, episomal form of viral DNA was therefore employed for 
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Southern blot analysis. Small amounts of episomal DNA derived from vector sequences has 
been routinely detected within VPC from both PAS 17 derived VPC. These episomal DNA 
were mainly detected in cytoplasmic fraction rather than nuclear fraction of VPC (Fig. 2). 
Analysis of LTKOSN.2 VPC demonstrated a single LTKOSN vector after probing for 
HSV^gene sequence on these episomal DNAs. However, probing with the Neo''gene on 
extracted episomal DNA from LTKOSN.2 VPC demonstrated a second smaller vector (Fig. 
3A, lane 1). To identify the primary structure of this second viral vector, restriction mapping 
and Southern blot analysis of the retroviral vectors was performed on the episomal DNA 
extracted from the cytoplasmic fraction of LTKOSN.2 VPC. Without restriction enzyme 
digestion, two respective sizes of episomal vector DNA were detected, 4.5-kb and 3.0-kb. 
Linear LTKOSN is represented by the 4.5-kb DNA band (Fig. 3A, lane 1). Ba/vHI digestion 
of the episomal DNA resulted in two fragments, 2.7-kb and 1.8-kb, being generated from the 
4.5-kb linear LTKOSN, while the second episomal proviral vector (3.0-kb) was resistant to 
BamHI digestion (Fig. 3A, lane 2). This suggests that the 3.0-kb DNA was possibly a mutant 
of LTKOSN with the BamHI site deleted. Serial re-hybridizations with different probes were 
employed to map the deletion region (Fig. 3A). The primary structure of this truncated 3.0-kb 
LTKOSN vector was found to include the S LTR, extended packaging signal (^ and portion 
of gag sequence), the Neo*" gene and the 3 LTR, but did not contain the HSVtk gene and 
SV40 promoter in this assay. PCR primers flanking the deletion region within extended 
packaging signal region and Neo''gene were used to amplify this deletion region from both 
LTKOSN.2 VPC genomic DNA and episomal DNA for sequencing analysis. The deletion 
region in the mutant vector, ALTKOSN, included the entire HSVtk gene (except the EcoRI 
polylinker region at its 5 end) and most of the SV40 promoter sequence (Fig. 3B). 
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DiSSCUSION 
The mechanism of origin of this ALTKOSN is still not defined and might represent 
simultaneous infections with two vectors when LTK0SN.2 VPC was established. The 
deletion of the HSVtk gene from the LTKOSN vector may have occurred during the 
transduction process of LTKOSN vector into PA317 packaging cells from GP+E86, and this 
conclusion Is supported by the fact that ALTKOSN vector was not detected in LTKOSN 
transfected GP+E86 VPC (15). 
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FIG. 1. Detection of second vector from LTK0SN.2 vector production. Viral RNA was 
extracted from virion particle pellet and subjected to Northern blot analysis. (A) Schematic 
diagram of LTKOSN vector and the probes. LTKOSN contains a HSVtk gene, which was 
cloned into the EcoRI site of LXSN. W, extended packaging signal region; Neo, neomycin 
phosphate transferase gene; SV, promoter sequence of simian virus 40 early gene. The 
probes were produced from LTKOSN vector by the following restriction endonucleases: B, 
BamH\; Bp, Bpml: E, EcoRI; H, Hindlll; K, h^n\; Sa, Sacll; Sp, Spel; St, Stul. (B) Two 
populations (4.5-kb and 3.0-kb) of vectors were detected from packaged viral transcripts by 
packaging signal probe (\j/) and Neor probe (Neo). Only one population (4.5-kb) of vector 
was detected by HStk probe (tk) probe. 
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FIG.2. Location of episomal DNA in vector producer cells. Nuclear and cytoplasmic 
fractions were separated by centrifugation after 1% Triton X-100 detergent treatment (2) 
(see Material and Methods). Vast majority of episomal DNA was detected in cytoplasmic 
fraction by Neo probe. 
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FIG. 3. Characterization of HSVtl< deleted LTKOSN (ALTKOSN) by episomal DNA 
restriction mapping. (A) Episomal DNA was extracted from the cytoplasm fraction of 
LTKOSN.2 VPC (see Materials and Methods). Without restriction digestion (lane 1), 
digestion with BamHl (lane 2) or SamHI/EcoRI (lane 3), these episomal DNA were 
transferred onto a nylon membrane and hybridized with different probes, LTR, tk, SV40 
promoter (SV40) and Neo"^, respectively. Without endonuclease treatment, LTKOSN vector 
is 4.5-kb and ALTKOSN vector is 3.0-kb in size. Note the absence of tk or SV40 probe 
hybridization to the ALTKOSN vector. (B) Schematic map of ALTKOSN was constructed as 
determined by Southern blot analysis. PGR primers were then designed to amplify the 
deletion region for sequencing analysis. A 1.5-kb region including the HSVtk gene and the 5 
portion of SV40 promoter was deleted. The EcoRI polylinker now joins with the 3 portion of 
SV40 promoter. Drawings are not to scale. 
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ABSTRACT 
Retroviral vector producer cells (VPC) have been considered genetically stable with 
a uniform vector integration pattem in the cell population for sustained vector production. In 
this study, we observed that the copy number of vectors is increased and varied in the 
population of established LTKOSN.2 VPC (Hum. Gene Ther. 7:1161-1179). A 
superinfection experiment demonstrated that this results from decreased Env-receptor 
interference by suppression of helper virus gene expression to allow increased 
superinfection by its own vector. In a particular subclone, the number of integrated vector 
was increased from 1 copy per cell to 9 copies per cell during a 31-day period of cell culture. 
Vector titer fell from 1.5 X 10® colony forming unit (cfu)/ml to 0 cfu/ml. To understand the 
involved mechanism, DNA methylation status of helper virus and vectors were examined by 
methylation-sensitive restriction enzyme digestion. We demonstrated that DNA methylation 
of helper virus 5' LTR occurred at 2% population per day and correlated closely with 
inactlvation of helper virus gene expression. In contrast, retroviral vectors did not exhibit 
significant methylation and show consistent transcription activity. Treatment with 5-
azacytidine (5-aza-C), a methylation inhibitor, partially reversed the helper virus DNA 
methylation and restored vector production. The preference for methylation of helper virus 
sequences over vector sequences may have important implications for host-virus 
interaction. Designing a helper virus to overcome cellular DNA methylation may therefore 
improve vector production and increase viral envelope-receptor interference to prevent 
replication-competent retrovirus (RCR) formation. 
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INTRODUCTION 
Retroviral vectors are the most commonly used gene delivery vehicles in human 
gene transfer trials (49). Permanent modifications of a targeted cell's genotype by the 
integration of a retroviral vector and the consistent production of retroviral vectors from 
permanent packaging cells (5, 31) offer significant advantages over other gene delivery 
vectors. Retroviruses convert their single-stranded RNA genome to double-stranded DNA 
(proviral DNA) by the activity of virus-associated reverse transcriptase (RT) after infection of 
target cells. The proviral DNA is permanently integrated into the cellular chromosomes as a 
provirus by viral integrase activity and then replicates as part of the host genome. The 
proviral DNA is then transmitted from one generation to the next if the virus is integrated 
into a germ line cell. The deletion of a provirus from its integration site is only observed in 
approximately one of 10® cells (52, 58). 
The major biosafety concern with retroviral vectors is replication-competent 
retrovirus (RCR) outbreak (1). RCR has been correlated with the occurrence of T-cell 
lymphomas in monkeys that had received RCR-contaminated bone marrow cell transplants 
(7, 57). Vector and helper virus rearrangement caused by abnormal template switches 
during the reverse transcription process has been considered the major cause of RCR 
formation (45, 57). Without Env-receptor interference, co-cultivation of VPCs with different 
host ranges, such as ecotropic and amphotropic VPC, can cause RCR formation in 3 to 10 
days depending on the number of recombination events necessary. The driving force for 
these recombination events is RT enzyme activity imported by the infection of the vector 
from the other VPC (37). 
During the vector assembly process, viral Env protein produced by the helper virus 
is transported to the cell membrane where it binds the cellular receptor used for virus entry 
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(30, 53, 59). This Env-receptor interference has been considered an efficient barrier to block 
the superinfection of vectors. The transduction efficiency of amphotropic vector on 
amphotropic PA317 packaging cells is reduced by six orders of magnitude from the 
amphotropic Env-receptor interference mechanism, compared to the transduction efficiency 
of the same vector on N1H3T3 (32). However, Env-receptor interference is not a complete 
block to superinfection. Most of cun-ently used retroviral packaging cells in gene transfer 
studies are based on either murine cells [/. e. NIH3T3 cells in GP+E86 (28) and PA317 (31)] 
or human cells [/. e. 293T cells in BOSC (46)] and express virus receptors. Thus, these 
packaging cells can still be infected by the vector they produce, albeit at low frequency (32, 
35). These vector re-entry events may lead to RCR formation. 
Suicide gene therapy against cancer cells by the combination of HSVf/c and 
ganciclovir (GCV) is a well-developed approach in human gene therapy trials (36, 42). We 
previously established a murine LTK0SN.2 VPC to transfer the HSVtfc gene by transducing 
a LTKOSN vector from GP+E86 to PA317 cells and demonstrated effective suicide gene 
therapy against breast cancer cells in vitro (26), colon carcinoma in vitro and in vivo (40), 
and human ovarian adenocarcenoma xenografts in vivo (27). In the current study of 
LTKOSN.2 VPC and derivative subclones, we observed significant genetic instability of 
several types, including a HSVf/c-deleted mutant vector found in addition to the original 
LTKOSN vector in the same VPC, increased copies of both vectors, a deleted provirus 
integration site, and a complete loss of vector production. To understand the mechanisms 
involved in these observations, we analyzed the DNA methylation status and the gene 
expression of vectors and helper virus. We demonstrated that transcriptional inactivation 
occurred of helper virus but not vectors. Significant DNA methylation of the helper virus 5' 
LTR region was observed in VPC subclones that lacked helper virus gene expression. 
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These same VPC subclones also had a loss of vector production and high vector copy 
number. A superinfection experiment demonstrated that these subclones are significantly 
susceptible to the re-entry of vector, compared to the other subclones. These findings 
suggest that DNA methylation may lead to VPC genome instability by reducing Env-receptor 
interference and permitting high levels of vector re-entry. (W.-B. Young is a doctoral 
candidate at Iowa State University, and this work represents partial fulfillment of his Ph. D. 
dissertation requirement.) 
MATERIALS AND METHODS 
Generation of LTK0SN.2 VPC and derived subclones. The construction of 
pLTKOSN and LTK0SN.2 VPC has been previously described (27). Briefly, a 1,201 bp of 
PCR-amplified HSVtk gene was cloned into the EcoRI site of pLXSN (34) (kindly provided 
by A. Dusty Miller, Fred Hutchinson Cancer Research Center, Seattle, WA) to produce 
pLTKOSN retroviral vector (Fig. 1 A). Ecotropic packaging cell line GP+E86 (28), a generous 
gift from Arthur Bank, Columbia University, was transiently transfected with pLTKOSN. 
Supemates from these GP+E86 cells were used to transduce the amphotropic retroviral 
packaging line PA317 (31), kindly provided by A. Dusty Miller. Forty different VPC clones 
were isolated and the LTK0SN.2 VPC produced the highest titer of 1.6 X 10® cfu/ml (27). 
The subclones of LTK0SN.2 in this study were obtained by limiting dilution of LTKOSN.2 
VPC onto two 96-well plates and examined by light microscopy to ensure that only single-
cell subclones were further analyzed. Six single-cell clones (#1-5 and #10) were identified 
and expanded for further study. 
Cell culture and drug treatment. Cell cultures were maintained in Dulbecco 
modified Eagle medium (DMEM; GIBCO BRL Life Technology Co., Gaithersburg, MD), 10% 
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fetal calf serum with 5% CO2, at 37°C. To reverse the DNA methylation, cells were grown in 
DMEM containing 5 of 5-aza-C (Sigma Chemical Co., SL Louis, MO) for 72 hr (25) and 
then subjected to the titer assay, vector RNA slot blotting and DNA methylation analysis. 
Retroviral infection. Vector titers were determined by the transduction of NIH3T3 
tk{-) cells [American Type Culture Collection (ATCC) CRL1658]. A375 cells (ATCC 
CRL1619, human melanoma) and IGROV cells [human ovarian carcinoma (56)] with 10-fold 
serial dilutions of vector stocks. Transduction was performed by incubating 1 X 10® cells/well 
in 6-well plates with vector in the presence of 10 ng/ml of protamine sulfate (Fujisawa USA 
Inc., IL) in 1 ml of DMEM. After transduction for 24 hrs, the cells were selected in medium 
containing G418 (1 mg/ml) for 10-14 days. Titers were obtained by multiplying the number 
of resistant colonies by the dilution factor. 
To perform superinfection assay on each subclone of LTKOSN.2 VPC, a LEIN 
retroviral vector carrying an enhanced green fluorescent protein (EGFP, (6, 10)) reporter 
gene was used to transduce LTKOSN.2 VPC subclones. This LEIN vector is based on an 
LXSN vector but with the replacement of intemal ribosomal entry site (IRES, (18)) for the 
SV40 promoter in LXSN. The EGFP gene was inserted in front of IRES to demonstrate 
transduction efficiency in target cells. Cells from NIH3T3, PA317, parental LTKOSN.2 VPC 
and LTKOSN.2 VPC subclones were seeded at 5 X 10® cells per well on 12-wells plates and 
exposed to 0.5-ml supemate of LEIN vector (3.4 X 10® cfu/ml) in the presence of 10 ^g/ml 
of protamine sulfate the day after seeding. Two days after a single exposure to LEIN vector, 
the transduction efficiency of these cell lines and VPC subclones was determined by 
fluorescence-activated cell sorter (FACS) analysis of EGFP expression (38) on an EPICS® 
Profile II Analyzer (Coulter Co., Miami, FL, USA). 
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Southern blot analysis of genomic DNA. Total cellular DNA was extracted from 
cell cultures using phenol/chloroform extraction and then dissolved in TE buffer (pH 8.0) 
overnight at 55°C (50). To study the copy number of integrated vector in these subclones, 
genomic DNA was digested by Kpnl to release nearly full length LTKOSN (4.0-kb) and 
ALTKOSN (2.5-kb) fragments (Fig. 1) and then Southem blotted for Neo'" probe detection. A 
0.7-kb BsfKl fragment of pPAM3 was used as a probe to detect a 2.5-kb DNA fragment of 
endogenous retroviral elements to demonstrate similar loading of DNA samples. To analyze 
for multiple integration sites in each subclone, SamHI was used to generate DNA fragments 
containing both proviral vector sequences and flanking chromosomal sequences. Southem 
blot analysis was performed and the duplicates of membrane were hybridized with Neo"^ and 
HSVtk probes, respectively (Fig. 2). 
RNA analysis of LTKOSN VPC and vector supernatants. Total cellular RNA was 
isolated from individual subclones using RNAeasy kit (Qiagen Inc., Valencia, CA). For virion 
RNA extraction, viral supernatant was subjected to 20% sucrose gradient ultracentrifugation 
(125,000 X g) for 2hr at 4°C for virion pelleting and then extracted by RNAzol (Biotecx, 
Houston, TX). Both cellular and virion RNA from each subclone were subjected to Northern 
blot analysis on a 1% agarose-0.4M formaldehyde gel. Vector transcripts were detected by 
a Neo''probe and helper viral transcripts were detected by a 1.4-kb env probe, which was 
digested from pPAMS by Xho\. RNA slot blotting of titer determination (39) was performed 
by applying 200 jal of supemates, directly collected from VPC medium and centrifuged at 
2,800 X g to eliminated the cellular debris, onto a slot blot apparatus (SlotBlot, Hoefer 
Scientific Instruments, San Francisco, CA). Vector RNA was UV-cross-linked onto this 
membrane and detected by a Neo*^ probe. 
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Methylation analysis. The methylation status of provlrus and vectors at the Smal 
site In the 5' LTR as determined by digestion of genomic DNA with Oral and EcoRV to 
reduce the DNA fragment size. The DNA was then precipitated with ethanol, re-dlssolved in 
sterile water and divided into two equal portions, one of which was subjected to methylation-
sensltive Smal restriction endonuclease digestion. The Southern blot membrane was 
hybridized with a 428-bp fragment of gag sequence {Pvu\\/Dra\) from pPAM3 to detect 
helper virus, a 273-bp EcoRI/EcoRV fragment of HSVtff sequence for LTKOSN vector, and 
a Neo*" probe to detect both LTKOSN and ALTKOSN, respectively (Fig. 7E). This Southern 
blot was also probed with an env probe to determine the methylation status of the Smal site 
In the helper virus RT region. DNA derived from NIH3T3 and PG13 (ATCC CRL 10686), a 
packaging cell line for gibbon ape leukemia virus (GaLV) pseudotyped vector (33), were 
used as negative controls. Densitometric analyses were performed with a Hoefer 
Densitometer GS300 (Hoefer Scientific Instruments) to measure the relative densities of 
Smal-sensitive band compared to DraUEcoRV band. Due to the interference from 
endogenous retroviral elements, the fraction of Smal methylation in 5' LTR was calculated 
as one minus the Intensity ratio of the Smal sensitive band (1.5-kb) divided by DraUEcoRS/ 
band (1.8-kb) as depicted in Fig. 5. 
RESULTS 
Dynamics of proviral DNA integration. We have previously detected a HSVtk-
deleted mutant vector (ALTKOSN) co-existing with full-length LTKOSN vector (Fig. 1A) in 
our LTKOSN.2 VPC population. To Investigate whether these ALTKOSN and LTKOSN 
vectors co-existed within the same individual cellular genome or existed separately in 
portions of the LTKOSN.2 VPC population, limiting dilution cloning on LTKOSN.2 VPC were 
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performed to isolate six single cell subclones (#1-5, and #10). After expanding the 
subclones to a sufficient cell population, each clone was then analyzed for integrated 
vectors by Kpnl digestion on both LTR regions to release the integrated proviral vectors of 
ALTKOSN (2.5-kb, Fig. 1A) and LTKOSN (4.0-kb, Fig 1A). Southern blot analysis 
demonstrated that both ALTKOSN and LTKOSN co-existed in the same individual cellular 
genome, since both vectors were detected in all six subclones (Fig. 1B). Varying copy 
numbers of ALTKOSN and LTKOSN were detected in subclones #2, #3 and #5. In contrast, 
only one single copy each of ALTKOSN and LTKOSN vector were detected in parental 
LTKOSN.2 VPC and subclones #1, #4, and #10. To estimate the copy numbers of 
integrated vectors, genomic DNA from each subclone was subjected to BamHl digestion 
and Southern blot analysis for the integration sites of both ALTKOSN and LTKOSN (Fig. 2). 
The BamH\ site is unique in the LTKOSN sequence, and restriction digestion yields two 
fragments of the LTKOSN vector with adjacent chromosomal sequences. Since the BamH\ 
site was deleted with the HSVf/c gene in ALTKOSN vector, only one genomic DNA fragment 
of integrated ALTKOSN vector with flanking chromosomal sequence is observed after 
SamHl digestion (Fig. 2B). The copy number of ALTKOSN was approximately six copies per 
cell in subclone #3, eight copies per cell in subclone 2, while only one copy of LTKOSN 
exists per cell in these two subclones. An increased copy number of LTKOSN was only 
observed in subclone #5, which showed approximately nine copies of LTKOSN and 
approximately 20 copies of ALTKOSN per cell. Therefore, significant changes in the vector 
copy numbers have occurred between the parental VPC and its subclones. 
Deletion of proviral integration site, in subclone #5, a possible deletion of an 
integration site of LTKOSN vector was observed (Fig. 2A). A 2.2-kb fragment (arrow) 
containing the 3' portion of proviral LTKOSN fragment with adjacent chromosomal 
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sequences was detected by the Neo*" DMA probe on parental LTKOSN.2 VPC and all of the 
subclones except subclone 5 (Fig. 2A, lane 7). A 4.5-kb fragment containing the entire 
ALTKOSN vector with adjacent cellular sequences on both ends was detected by the same 
Neo'"DNA probe on all of the subclones and parental LTKOSN.2 VPC. In addition to the 4.5-
kb and 2.2-kb bands detected in subclones #2 and #3, other bands that are larger than 2.2-
kb should be ALTKOSN vector, since only one integration site of LTKOSN (3.7-kb) was 
detected by HSVtk probe on the same membrane in subclones #2 and #3. This 3.7-kb 
fragment (arrow) containing the 5' portion of LTKOSN with adjacent chromosomal 
sequences was detected in the LTKOSN.2 VPC and all subclones except subclone #5 (Fig. 
2A, lane 7). Taken together, the original LTKOSN vector integration site, present in the 
parental LTKOSN.2 VPC and the other subclones, appears absent in subclone #5 (Fig. 2A, 
lane 7). Since subclone #5 still contains the same integration site (4.5-kb band) 
of ALTKOSN as seen in parental LTKOSN.2 VPC and the other subclones, subclone #5 is a 
true subclone derived from parental LTKOSN.2 VPC. We also suspect that Subclone #5 
may be derived from subclones #2 and #3, since subclone #5 shares a very similar 
integration pattern of ALTKOSN with subclones #2 and #3. 
Gene expression and packaging of ALTKOSN and LTKOSN. After Northern blot 
analysis of RNA transcripts from subclones #1, #3, #4, #5 and #10 (subclone #2 was lost to 
contamination), the results revealed that the RNA transcript ratio of ALTKOSN/LTKOSN in 
all of the subclones was approximately 2:1 or greater (Fig. 3A). This ratio was observed in 
subclones #1, #4 and #10 that contain only one copy of each ALTKOSN and LTKOSN 
vector. This could result from differences in the integration sites or the smaller size 
of ALTKOSN. Previous reports demonstrated that the internal SV40 promoter, present in 
LTKOSN but deleted from ALTKOSN, can interfere with transcription from the 5' LTR (47). 
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Subclone #5, which contains the highest copy nunnber of both ALTKOSN and LTKOSN 
vectors, showed more abundant vector transcripts than the other subclones. Unexpectedly, 
these abundant vector transcripts in subclones #1, #3 and #5 were not packaged into 
virions (Fig. 3B). 
Transcriptional inactivation of helper virus. To determine the mechanism for the 
observed reduction of vector production in subclones #1, #3 and #5, Northern blots of 
subclones were probed with amphotropic env DNA to evaluate the level of helper virus gene 
expression (Fig. 3). Spliced env transcripts were detected in all subclones, but significant 
levels of full-length helper virus transcripts were only observed in subclones #4 and #10 
(Fig. 3A) that were previously shown to produce virions containing ALTKOSN and LTKOSN 
vectors (Fig. 3B). It has been reported that spliced RNA (e.g., env transcript) is more stable 
than precursor RNA (e.g., full-length helper virus) as a result of increased polyadenylation 
efficiency on RNA 3' processing (13). Therefore, the overall low level gene expression of 
helper virus and faster degradation of full length helper virus transcripts may explain why 
only env transcripts were observed in subclones #1, #3, and #5, but not full-length helper 
virus (Fig. 3A). These results demonstrated that the reduction of packaged ALTKOSN and 
LTKOSN vectors in subclones #1, #3 and #5 correlated closely with low levels of helper 
virus gene expression. 
Superinfection of LTKOSN.2 VPC subclones. To test our hypothesis that the 
supression of helper virus gene expression by DNA methylation reduces the Env-receptor 
interference, and then results in vector re-entry (superinfection), LTKOSN.2 VPC subclones 
were transduced with an EGFP-expression vector, LEIN (see Materials and Methods). The 
transduction efficiency of LEIN vector on these subclones was determined by FACS 
analysis of EGFP expression compared to NIH3T3. PA317 and parental LTKOSN.2 VPC 
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(Rg. 4). NIH3T3 cells that do not express Env protein on the cell surface were 21.9% EGFP 
positive two days after single exposure to LEIN vector. LTK0SN.2 VPC subclones with 
significant DNA methylation in the 5' LTR region were transduced at cpmparable rates to 
NIH3T3 cells (15.7% to 19.3% in subclones #1, #3 and #5). Subclones #4 and #10 that 
exhibited less methylation of the 5' LTR and more detectable helper virus transcripts were 
transduced at lower rates of only 0.6% and 1.4% which were comparable to PA317 (0.2%) 
and parental LTKOSN.2 VPC (0.4%). These results demonstrate that the DNA methylation 
status and gene expression of helper virus in these subclones correlated closely with the 
superinfection of LEIN vector. These results also suggested that the increased copy number 
of LTKOSN and ALTKOSN in subclones #3 and #5 is due to superinfecion. Subclone #1 
showed high DNA methylation, helper virus gene inactivation and superinfection of LEIN 
vector as well as subclones 3 and 5, but did not exhibit increased copy number of vectors. 
We suspect that the methylation occurred during or after the subcloning procedure, since 
we did observe that the titer of subclone #4 was completely reduced to non-detectable by 
DNA methylation in one month period of cell culture (Table 2, see below). Subclone #1 
therefore did not produce any vector from then and consistently with one single copy of 
each vector without any vector re-entry. 
Methylation status of helper virus and retroviral vectors. DNA methylation has 
been demonstrated to be associated with the repression of retroviral vector gene 
expression in different cells and tissues in vitro (12, 21, 23) and in vivo (3). The methylation 
of CpG within a Smal site by mammalian methylase will prevent Smal digestion (48). The 
methylation status of the Smal site in 5' LTR has been employed to demonstrate an inverse 
correlation with the gene expression levels of retroviral vector (3). Therefore, the same 
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analysis was perfomned to detect helper virus DNA methylation (Fig. 5) compared to helper 
virus gene expression in VPC subclones (Fig. 3A). 
Genomic DNA was first digested with EcoRV and Dral to generate a DNA fragment 
convenient for Southern blot analysis. An equal portion of this EcoRVfDral digested DNA 
was subjected to Sma\ digestion. Since the gag region is not present in the retroviral vector, 
a 428-bp gag probe hybridizes only to the helper virus DNA (Fig. 5A and 5E). All of the 
subclones and parental VPC showed a 1.8-kb EcoRV/Dral band (lanes 11-18), which was 
reduced to a 1.5-kb band upon Smal digestion if no methylation occurred at the Smal site. 
This 1.5-kb band was not detected in either NIH3T3 cells or subclone #5 (Fig. 5A, lanes 1 
and 7), but was observed in all other samples. NIH3T3 cells were used to show the 
presence of endogenous retroviral elements that hybridized with the gag probe (Fig. 5A, 
lanes 1 and 10). After Smal digestion of NIH3T3-derived DNA, a band of approximately 1.8-
kb was generated from endogenous retroviral elements that complicates our analysis (Fig. 
5A, lane 1). Therefore, the methylation status of the Smal site was evaluated by the relative 
intensities of the observed 1.5-kb bands from Smal/EcoRV/Dral digestions (lanes 2-9) 
compared to 1.8-kb bands from EcoRV/Dral digestions (lanes 11-18), which do not overiap 
in size with endogenous sequences (Fig. 5A, lane 10). Although 40% of helper virus 5' LTR 
in PA317 is methylated (Fig. 5A, lane 2), complete digestion by Smal shows the apparent 
absence of methylation of the helper virus 5' LTR In parental LTKOSN.2 VPC (Fig. 5A, lane 
3). This suggests that the prior selection of LTKOSN.2 VPC, that was chosen for its high 
titer compared to the other VPC clones, is likely the result of both high level expression of 
vector and low methylation of helper virus. A high degree (60%) of helper virus methylation 
is also found in the 5' LTR of PG13, a GaLV pseudotyped VPC (Fig. 5A, lanes 9 and 18). 
This indicates that the methylation of helper virus 5' LTR In PA317 is not a single packaging 
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cell line phenomenon. In contrast to the low level of helper virus methylation in parental 
LTKOSN.2 VPC, higher degrees of helper virus DNA methylation were observed in the 
subclones (Fig. 5A). This high level of methylation was inversely proportional to the helper 
virus gene expression (Fig. 3A) and subsequent packaged vector titer (Fig. 3A and Table 1). 
Subclone 5 has an absence of the 1.5-kb band, which indicates complete methylation of the 
helper virus 5' LTR (Fig. 5A, lane 7). 
The methylation status of the Smal site in the RT region of the helper virus was 
evaluated by the re-hybridization of this Southem blot with a 1.4-kb env probe (Fig. 5B). In 
subclones #1, #3 and #5, that had highly methylated helper viral 5' LTR, the methylation 
level of Smal in the RT region ranged from 46% to 100%. In contrast, only 3% to 10% 
methylation were observed in parental LTKOSN.2 VPC and subclones #4 and #10. Thus, a 
strong correlation exists between the observed methylation of the Smal site in 5' LTR and 
within the RT gene (Fig. 5A and 5B). In addition to the 4.6-kb band in the DNA samples 
without Smal digestion (lanes 10-18), three additional bands were observed in parental 
LTKOSN.2 VPC and all VPC subclones (lanes 2-8; lanes 10-17), but not in NIH3T3 and 
PG13 (lanes 1 and 10; lanes 9 and 18). These results demonstrate that the env probe is 
specific for the env sequence of helper virus pPAMS and does not detect GaLV env or 
MoMLV gag-pol from PG13 cells. Furthenmore, at least four copies of env sequence are 
present in the PA317 genome. These multiple copies of helper virus env sequence were 
confirmed by Southem blot analysis of PA317 genomic DNA with different methylation-
insensitive restriction endonuclease digestions (data not shown). In contrast, hybridization 
with probes for either the HSVtfc (Fig. 5C) or Neo"" gene (Fig. 5D) reveals no significant 
methylation within either LTKOSN or ALTKOSN vectors. Extremely low methylation of the 
5' LTR of LTKOSN and ALTKOSN vectors was only observed in subclone #5 (Fig. 5D, lane 
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7), which showed 100% methylation in both the helper vlais 5' LTR and RT region (Rg. 5A 
and 5B, lane 7). 
Parental LTKOSN.2 VPC does not show significant methylation of either helper virus 
or vectors. However, the subclones derived from LTKOSN.2 VPC show various methylation 
levels of the helper virus but not of their retroviral vectors. These results suggest a 
sequential timeline of methylation that developed within the helper virus DNA in these five 
subclones. These data also support our previously theorized cell lineage relationship, based 
upon the similarity of vector integration patterns observed in Fig. 2A. 
Reversal of DNA methylation. To re-activate silenced helper viruses, these 
subclones were treated with 5-aza-C, a cytidine analog that can inhibit DNA methylase and 
reverse methylation to restore gene expression (8, 20, 22, 25). After co-culturing with 5-aza-
C for 72 hr, the rescue of vector RNA from these VPC subclones was demonstrated by 
RNA slot blot analysis of supernates (Fig. 6). Partial recovery of vector production was also 
demonstrated by titer assay (Table 1) along with the partial reversal of DNA methylation by 
5-aza-C treatment (Fig. 7). The titer of subclones #1, #3 and #5 were increased by two 
orders of magnitude from <10 cfu/ml to up to 6 X lO^cfu/ml. No significant change was 
observed in subclones 4 and 10 that exhibited high vector production and less helper virus 
methylation before 5' aza-C treatment. The most significant reduction of Smal resistance 
was observed in subclone 5 In which the methylation of the 5' LTR and RT regions was 
reduced from 100% to about 45% on Southern blot analysis (Fig. 7. lane 4). In this model 
system, we conclude that the methylation of helper virus Is responsible for the reduction of 
vector production. 
DNA methylation rate of helper virus 5' LTR. To study the DNA methylation rate 
of helper virus 5' LTR, we examined the DNA methylation of subclone #4, which showed the 
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least DNA methylatlon with most activate gene expression among these subclones. During 
31 days of continuous cell culture, DNA methylation of helper virus 5' LTR in subclone #4 
increased rapidly from 36% to 100% (Fig. 8A). Therefore the methylation rate of Smal site 
in helper virus 5' LTR was calculated as high as 2% population per day. The copy numbers 
of vector were increased from 1 copy (parental LTK0SN.2 VPC and subclone #4 on Day 0) 
to 5 copies (Day 7) and subsequently to 9 copies (Days 23 and 31) per cell (Fig. SB and 
8C). Titer of this subclone #4 was reduced from 1.5 X 10^ cfu/ml (Day 0) to no detectable 
titer by Day 23 (Table 2). The reduction in vector titer correlated with increasing inactivation 
of helper virus gene expression (Fig. 9A). However, vector gene expression still remained at 
high levels (Fig. 9B). Only minimal DNA methylation (10%) of 5' LTR was observed in 
LTKOSN vector and no detectable DNA methylation was noted in the ALTKOSN vector (Fig. 
80). 
DISCUSSION 
In this study, the genetic stability of retroviral vectors and a VPO genome was 
examined in LTKOSN.2 VPO and derived subclones. We also compared the methylation 
status of helper virus and vectors in these individual subclones. Our results demonstrate 
that DNA methylation occurred of helper viral sequences rather than vector in subclones 
derived from LTKOSN.2 VPO (Fig. 5). The increase in methylation of the helper virus (Fig. 5 
and Fig. 8) correlated directly with the inactivation of helper virus gene expression (Fig. 3 
and Fig. 9), which resulted In a loss of vector production. In contrast, vector gene 
expression was consistent and no significant methylation of vector sequences was 
detected. Therefore, we conclude that the key limitation for vector production in the 
LTKOSN.2 VPO is the inactivation of helper virus gene expression by DNA methylation. 
49 
This conclusion was supported by the partial restoration of vector production (Table 1) and 
the reversal of DNA metiiylati'on (Fig. 7) from VPC subclones treated with 5-aza-C. In 
previous studies, de novo DNA methylation has been suggested to cause transcriptional 
inacti'vation of retroviral vectors in infected embryonic cells (3,12, 21). Thus far, DNA 
methylation had not been a focus of investigation with regard to the genetic instability of 
retroviral VPC that are designed for continuous vector production. The methylation of helper 
virus sequence in a VPC may initiate a cascade of more complex events compared to the 
inactivation of vector gene expression noted in infected embryonic cells. The methylation of 
helper virus 5' LTR resulting In the genetic instability of VPC is proposed by this study to 
occur in the following sequence: (i) repression of helper virus 5' LTR transcriptional activity 
by methylation reduces the production of vector, (ii) decreased Env protein synthesis 
reduces Env-receptor interference and allows vector superinfection to cause increased 
vector copy number in VPC, and (iii) random integration of vectors caused by 
superinfection results in a more fluid VPC cellular genome. 
The reason for the preference for methylation of the helper virus compared to the 
retroviral vectors is not clear and requires further studies. However, chromosomal location 
has been suggested as a key factor for facilitating methylation (12, 19). In PA317, four 
copies of env sequences of pPAMS helper virus were observed (Fig. 5B). Further restriction 
analysis of these helper virus sequences demonstrates that the sequences are located at 
different chromosomal sites (data not shown). The probability that all four copies of helper 
virus sequences are located within a hypermethylation region of PA317 seems remote. No 
significant methylation of vectors was observed in subclones 3 and 5, even though these 
subclones contain multiple copies of vectors, which were distributed into different integration 
sites. About 100 copies of integrated MoMLV provirus have been observed in infected 
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murine embryonic carcinoma cells and these proviruses were hypermethylated with no 
significant gene expression (54). Presumably, these 100 copies of provirus were not all 
located In hypermethylation regions. Therefore, the preference of methylation for helper 
virus is probably related to both helper virus sequence and chromosomal location. The idea 
that sequence has an important role is also suggested by the findings that the presence of 
retrotransposon and provirus sequences enhance the de novo DNA methylation of adjacent 
sequences (11, 16). Most recently, experiments provided evidence that DNA methylation 
acts as a defense system against retrotransposons invading the mammalian genome (43). 
infection of retrovirus, such as HIV, increased the overall DNA methyltransferase gene 
expression and activity, which resulted in supression of cytokine gene expression for 
evading immune surveillance (29). The spreading of de novo methylation from a provirus 
into adjacent cellular sequences was observed in either the 5' or 3' region of the integration 
site in Mov-derived mice carrying a MoMLV provirus in a distinct chromosomal location (16). 
In the pPAM3 LTR, the significant methylation observed could be the result of spreading of 
methylation from adjacent gag sequences, since the LTR in either LTKOSN or ALTKOSN 
vector did not initiate any significant methylation. However, we did not rule out the role of 
chromosomal position and preferred DNA methylation (12). These subclones of VPC may 
provide a useful model to study DNA methylation preferences that are key in host-retrovinjs 
interactions (11, 16, 17, 29, 43). 
One may argue that G418 selection of VPC could have eliminated VPC cells with 
methylated vectors. After the establishment of LTK0SN.2 VPC, VPC were not maintained 
on G418 selection on a continual basis. Other LTKOSN parental lines only require a single 
copy of the Neo"^ gene for G418 resistance. Subclones #3 and #5 contained multiple copies 
of LTKOSN and ALTKOSN. Even if partial methylation of the vector as noted in the helper 
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virus had occurred, adequate Neo*^ gene expression would nevertheless provide G418 
resistance. However, almost no methylation was observed in either LTKOSN or ALTKOSN. 
Extrenriely low degree of nnethylation was only observed in subclone #5 which contains 
approximately 29 copies of integrated vectors, and this could be contributed by the random 
integration of these vectors into hypermethylation regions of cellular genome. In contrast to 
the moderate degree of methylation (40%) of the helper virus 5' LTR in PA317, the helper 
virus in parental LTKOSN.2 VPC did not show significant methylation of Smal sites in the 5' 
LTR. This demonstrates that a diverse range of methylation status exists within PA317 cells 
and the selection of the highest titer LTKOSN VPC (LTKOSN.2) from among the other 39 
clones may have selected for a clone with hypomethylated helper viruses. 
It has been well documented that Env-receptor interference is important to reduce 
the risk of superinfection (30, 32, 53, 59). Recent data demonstrated that at least four 
copies of retrovirus per cell are required for sufficient Env protein synthesis to interfere with 
the cellular receptor (41). Superinfection experiments on these LTKOSN.2 subclones (Fig. 
4) demonstrated that DNA methylation (Fig. 5) and helper virus mRNA level (Fig. 3) are 
highly correlated with the reduction of Env-receptor interference. The reduction of env gene 
expression by DNA methylation would logically result in the re-entry of multiple vectors into 
subclones #3 and #5. Subclone #1 may represent a transitional state between the parental 
LTKOSN.2 and subclone #3 since only one copy of each LTKOSN and ALTKOSN vector is 
present while helper virus gene expression is low. 
DNA methylation in subclones #4 and #10 (38% and 50%, respectively) and PA317 
(40%) is significantly higher than in parental LTKOSN.2 cells (0%). However, the resistance 
to superinfection in subclones #4, #10 and PA317 is still comparable to that observed in 
parental LTKOSN.2 cells (0%, Fig. 5). A significant increase in superinfection was only 
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observed in subclones when at least 60% methylation occurred of the helper virus 5' LTR. 
This suggests a possible threshold effect. It has been dennonstrated that the amount of Env 
product per cell, the interference and virion release did not increase lineariy but increased 
abruptly once an infected cell reached the threshold of proviral copy number which 
correlated with mRNA level (41). This is due to the fact that oligomerization of Env protein is 
essential for functional virus assembly and interference (2, 14, 41). Since the concentration 
of Env protein determines the kinetics of oligomerization, reduction of helper virus mRNA 
level by DNA methylation resulted in low Env protein concentration and oligomerization, 
and, therefore significantly decreased the Interference and virion release. Compared to the 
previously reported high level of resistance to the superinfection of PA317, which was 
transduced with the vector collected from another PA317 VPC (32), the apparent re-entry 
frequency of vectors in LTKOSN.2 VPC is relatively high (50% of population, three out of six 
subclones. Fig. 1). This superinfection was enhanced by both the DNA methylation of helper 
virus and the presence of extensive vector exposure in cell culture. It has also been 
observed that HIV provirus was accumulated in infected cells to multiple copies by 
superinfection of 70% of cells in the culture over time (44). 
Amphotropic murine leukemia virus (Am-MLV) vectors are used widely for human 
gene transfer. However, most Am-MLV VPCs are derived from murine cells and are 
susceptible to vector re-entry. The consequence of vector re-entry is the import of active RT 
enzyme which may lead to the RCR formation and the random integration of additional 
vectors that can interrupt functional genes or activate proto-oncogenes (9, 15, 24, 51). Our 
results infer that DNA methylation decreases the Env-receptor interference, which results in 
vector re-integration and subsequent further instability of the VPC genome. Recently, 
progress in this direction has been made: PG13 VPC were established using NIH3T3 cells 
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for packaging xenotropic GaLV-pseudotyped vector. GaLV packaged vector will not re-infect 
PG13 cells that lack the receptor for GaLV envelope (33, 60). PG13 VPC may diminish the 
vector re-entry problem; however, helper virus gene expression in PG13 is still not 
monitored and selected by a selection marker. Our data with PG13 show significant DNA 
methylation (60%) of helper virus 5' LTR (Fig. 5A, lanes 9 and 18). The observations in this 
study strongly suggest that improvement of the helper virus gene expression to overcome 
DNA methylation in VPC is important for sustained, stable vector production. Treatment with 
5-aza-C on LTK0SN.2 subclones did not completely restore the titer (Table 1). The effect of 
5-aza-C treatment is transient (8) and can not be applied to long term cell culture since 5-
aza-C is toxic to the treated cells (20). Several alternative strategies that ensure sustained 
vector gene expression in target cells might improve the gene expression of helper virus in 
VPC. Insertion of a demethylation fragment of murine Thy-1 gene in front of 5' LTR can 
inhibit methylation (4, 55) and may be useful for helper virus. Another strategy is to ligate an 
internal ribosome entrance site [IRES, (18)] with a selection marker gene downstream of the 
helper virus so that drug selection would ensure active enhancer/promoter function of helper 
virus for high vector packaging and preventing superinfection by enhancing Env-receptor 
interference (61). 
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TABLE 1. Titer of LTKOSN.2 sub-clones treated with S-aza-C 
Target cell 
5-aza-C NIH3T3 A375 IGROV 
Sub-clone 1 + 4X10^ 
1  X10^ 
5X10^ 
2X10°  
4X 10^ 
0 
Sub-clone 3 -1- 4X10^ 
0 
6X10^ 
0 
SXIO""  
0 
Sub-clone 4 
+ 5X10® 
2 .2X10® 
4X10® 
4X10® 
1 X 10® 
ax io ' ^  
Sub-clone 5 + 2X10^ 
0 
3X10^ 
0 
1.8 X 10^ 
0 
Sub-clone 10 + 3X10"^ 
4X10"^ 
1  X10® 
2X10® 
1.2X10"^ 
1.6 X lO'^ 
TABLE 2. Decreased titer of LTKOSN.2 VPC subclone #4 
in continuous cell culture 
Subclone #4 
LTKOSN.2 Day 0 Day 7 Day 23 Day 31 
1.1 X 10® 1 .5X10® 7X10"^ 0 0 
FIG. 1. Increased copy number of LTKOSN and ALTKOSN in LTKOSN.2 subclones. 
(A) Schematic diagram of LTKOSN and ALTKOSN vectors. LTKOSN contains a HSVtfc 
gene, which was cloned Into the EcoRI site of LXSN. extended packaging signal region; 
Neo, neomycin phosphate transferase gene; SV, promoter sequence of simian virus 40 
early gene. B, SamHI; Bp, Bpm\; E, EcoRI; H, Hindlll; K, Kpni. (B) Genomic DNA was 
extracted from GP+E86 transfected with LTKOSN (lane 1), parental LTKOSN.2 (lane 3) and 
Its derived subclones #1, #5 and #10 (lanes 4-9). PA317 derived DNA (lane 2) was used as 
a confrol. Kpnl digests within both U5 regions of LTR and releases a full-length provlral 
LTKOSN without the 5 LTR (4.0-kb) and a ALTKOSN without the 5 LTR (2.5-kb). Integrated 
LTKOSN and ALTKOSN were detected from parental LTKOSN.2 and all subclones, but not 
PA317 cells. Only LTKOSN vector was detected in LTKOSN-transfected GP+E86 cells. 
Note the relative variance in ALTKOSN copy number of different subclones compared to 
LTKOSN. (C) Hybridization with a BsfKl fragment probe (0.7-kb, located at gag coding 
region) that detects a 2.5-kb fragment of Kpnl digested endogenous retroviral sequences 
showed similar loading of DNA samples. 
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LTKOSN vector 
4.0 kb 
HSVtk LTR Neo LTR 
TK probe Neo probe 
ALTKOSN 2.5 kb 
K K 
LTR Neo f-fTjR 
CO 
S 
Sub-clones 1 
2 3 4 5 10 
2.0-
- LTKOSN 
-ALTKOSN 
3.0-
2.0-
1  2 3 4 5 6 7 8 9  
FIG. 2. Genetic instability of integrated LTKOSN in VPC genome. (A) Genomic 
DNA extracted from PA317 (lane 1), LTK0SN.2 VPC (lane 2) and its subclones (lanes 3-
8) were subjected to SamHI digestion and detected by Neo*^ and/or HSVf/c probes in 
Southern analysis. Only two integration sites were detected on parental LTKOSN.2, 
subclones #1, #4, and #10, but subclones #2, #3 and #5 showed more integration sites. 
The arrows indicate the positions of integrated LTKOSN vector. Note the absence of 
these bands from subclone 5 on botii Neo"^ and HSVtfc probe hybridizations. (B) Schema 
of LTKOSN and ALTKOSN integration sites showing the locations of SamHI sites on the 
flanking chromosomal sequences. The SamHI site on ALTKOSN is deleted, therefore, 
digestion with SamHI excises the entire ALTKOSN at the 5' and 3' flanking chromosomal 
DNA sequence (4.5-kb) of the integration site. SamHI digestion excises the LTKOSN 
backbone 5' to the SV40 promoter and results in two fragments of 3.7-kb and 2.2-kb. 
which includes 5' and 3' junctional chromosomal DNA sequences, respectively. 
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_L 
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Neo hTlTR ALTKOSN 
4.5 kb 
FIG. 3. Differential gene expressions of vectors and lieiper virus in LTKDSN.2 
VPC subclones. (A) Total RNA was extracted from LTKOSN.2 VPC subclones (lanes 3-
7) and detected by Neo^ env and human glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) cDNA probe. RNA transcripts of LTKOSN and ALTKOSN are 4.0-kb and 2.5-
kb in size, respectively. RNA extracted from NIH3T3 (lane 8) was used as a negative 
confrol. Hybrid'czation with env probe detected helper virus gene expression. Compared to 
the spliced env transcript observed in all of subclones, full-length MoMLV transcript (gag-
pol-env) was only detected in LTKOSN.2 VPC (lane 2) and subclones #4 and #10 (lanes 
5 and 7) and barely seen in otiier subclones and PA317 cells. (B) Viral RNA extracted 
from viral particles was detected by Neo"" probe and showed that LTKOSN and 
ALTKOSN transcripts were detected only in the supemates collected from subclones #4 
and #10. Thus, despite abundant LTKOSN and ALTKOSN transcripts in the VPC, little or 
no vector was packaged and released from subclones #1, #3 and #5. 
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<M 
Probe kb 
4.4-
Neo 
env 
GAPDH 
Sub-clones 
— LTKOSN 
— ALTKOSN 
— Neo 
— gag-pol-env 
— env 
1 2 3 4 5 6 7 8 
CM 
Sub-clones 
LTKOSN 
ALTKOSN 
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FIG. 4. Superinfection susceptibility of LTK0SN.2 VPC subclones. Cells from 
NIH3T3. PA317, parental LTKOSN.2 and LTK0SN.2 VPC subclones were seeded at 5 X 
10® cells per well on 12-wells plate and exposed to 0.5 ml supemate of EGFP-expressing 
vector, LEIN (3.5 X 10® cfu/ml, see Materials and Methods). FACS analysis of EGFP 
expression was performed 2 days after the single exposure of LEIN vector. The average of 
three transduction rates of each target cell line was, NIH3T3, 21.9%; PA317, 0.2%; 
LTKOSN.2, 0.4%; subclone #1,18.4%; subclone #3, 15.7%; subclone #4, 0.6%; subclone 
#5, 19.3%; and subclone #10, 1.4%. Error bars were calculated from triplex transduction 
data of each target cell line. 
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30 
25 
Target cell line 
FIG. 5. DNA methylation statuses of helper virus and vectors. Genomic DNA was sequentially digested with Dra\ and 
EcoRV, precipitated with ethanol, resolved in sterile water, divided into two equal portions for Sma\ digestion (lanes 1-9) or 
without Smal digestion (lanes 10-18). (A) Hybridization of gag DNA probe to detect helper virus 5 LTR. Sma\ digestion reduced 
the 1.8-kb band (lanes 11-18) to 1.5-kb (lanes 2-9). DNA from NIH3T3 cells was used to demonstrate the presence of 
endogenous retroviral elements (lanes 1 and 10). Since a 1.8-kb band was generated from endogenous retroviral element after 
Smal digestion (lane 1), the values for Smal resistance were measured by densitometry as the relative intensities of the 1.8-kb 
bands without Smal digestion (lanes 10-18), and 1.5-kb bands generated after Smal digestion (lanes 1-9). Note the absence of 
helper virus methylation in parental LTK0SN.2 (lane 3) and completely methylated helper virus 5' LTR in subclone 5 (lane 7). (B) 
Re-hybridization of env DNA probe for the Smal methylation status in helper virus RT region. Smal resistance was measured as 
the relative intensities of the 4.6-kb and (3.3-kb + 4.6-kb) bands generated after Smal digestion. Note multiple copies of helper 
virus env sequences were detected in PA317 and derived cells. (C) HSVf/c DNA probe was used to detect the 5 LTR of LTKOSN 
vector. Smal digestion reduced the 1.5-kb fragment to 1.2-kb. The varied signal intensities are secondary to the copy number of 
LTKOSN vector in each subclone. (D) Neo' probe was used to detemriine the Smal methylation status in both the HSVtk gene of 
LTKOSN and the 5 LTR region of ALTKOSN. Smal reduced the 2.4-kb fragment of ALTKOSN to 2,1-kb, and the 2.1-kb band of 
LTKOSN to 1.5-kb. (E) Schemes of the helper virus and vectors showing the locations of restriction enzyme sites and the probes 
used for the methylation analysis. D, Oral; E, EcoRV; S, Smal; AAA, SV40 poly (A) signal. Drawings are not to scale. 
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FIG. 6. Treatment with 5-aza-C partly restores the vector production ability in 
subclones. Cell cultures were co-incubated with 5 ^ iM of 5-aza-C for 72 hrs. Supernate (200 
fil) collected from each of the cell culture with or without 5-aza-C treatment was loaded onto 
the slot blot apparatus and UV-cross-linked onto a nylon membrane. Neo"" probe was used 
to detect the LTKOSN and ALTKOSN vector transcripts to quantify the vector production 
ability of each subclone, supernate collected from NIH3T3 was used as a negative control. 
FIG. 7. Treatment with 5-aza-C reverses the DNA methylation of helper virus. 
Genomic DNA digestion and hybridization with the gag (A) and env(B) DNA probes were 
the same as described in Fig. 5 to evaluate the Smal methylation status in the helper virus 
5 LTR and RT regions. Note the new appearance of a 1.5-kb band (A) and a 3.3-kb band 
(B) in subclone 5 (lane 4), that were not seen in Fig. 5 (lane 7) before 5 aza-C treatment. 
75 
— + Smal — Smal — 
I— Sub-clones —| [— Sub-clones —| 
% Smal- ^ ^ ^ ^ 
Resistance £8 S co ^ ^ 
B 
1  2 3 4 5 6 7 8 9  1 0  
% Smal- ^ ^ ^ ^ 5^ 
lO O) LO O O Resistance cm oa •«- to 
FIG 8. Increased DNA methylatlon In helper virus of subclone #4 overtime. Genomic 
DNA was first digested with Dral and EcoRV, and divided into two equal portions for Smal 
digestion as described in Figure 5. (A) Hybridization of gag DNA probe to detect helper virus 
5 LTR. Smal digestion reduced the 1.8-kb band (even number lanes 4-14) to 1.5-kb (odd 
number lanes 3-13). Smal resistance was calculated as previous in Figure 5. (B) HSVtk 
DNA probe was used to detect the 5 LTR of LTKOSN vector. Smal digestion reduced the 
1.5-kb fragment to 1.2-kb. The values for Smal resistance were calculated as described In 
Figure 5. The varied signal Intensities are secondary to increasing copy numbers of 
LTKOSN vector over time. Copy number was estimated by comparing relative intensity of 
HSVtk signals and intensities detected by SsfiCI fragment probe (D) to standardize loading. 
Increased copy numbers were observed on Days 7 (5 copies, lane 10), 23 and 31 (9 copies, 
lane 12 and 14), while only one copy In parental LTKOSN.2 and subclone #4 on Day 0 
(lanes 6 and 8). (C) Neo"" probe was used to determine the Smal methylatlon status in both 
the HSVf/c gene of LTKOSN and the 5 LTR region of ALTKOSN. (D) A 0.68-kb DNA 
fragment firom gag gene digested by BsfK\ was used as a probe to detect a 1.2-kb band of 
endogenous retroviral sequence to demonstrate equivalent DNA loading In paired samples 
of Smal digestion. 
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FIG. 9. Transcription activity of helper virus and retroviral vectors in LTK0SN.2 VPC 
subclone #4. (A) Northern blot analysis of cellular RNA extracted from LTKOSN.2 subclone 
#4 at different time points was hybridized with env probe. Unspliced MoMLV transcript (gag-
pol-env) were detected at different sizes as a result of the presence of at least four different 
integrated pPAM3 detected in PA317 with different adjacent sequences. (B) Gene 
expression of LTKOSN and ALTKOSN vectors. Re-hybridlzation of this Northern blot 
membrane with Neo"^  probe to detect LTKOSN vector (4.0-kb), ALTKOSN vector (2.5-kb) 
and a Neo"^  RNA transcript (1.2-kb) derived fi-om intemal SV40 promoter activity. (C) 
Hybridization with GAPDH cDNA probe demonstrated similar levels of RNA loading. 
79 
kb 
Helper 
Virus 4.4-
2.4-
CVi 
z 
CO 
s 
Sub-clone #4 
I 1 
Day 
0 7 23 31 
unspliced* 
env 
Vector 
4.4- LTKOSN 
ALTKOSN 
neo 
GAPDH 
1 2 3 4 5 
80 
CHAPTER 4. CHIMERIC RETROVIRAL HELPER VIRUS AND PICORNAVIRUS IRES 
SEQUENCE TO ELIMINATE DNA METHYLATION FOR IMPROVED RETROVIRAL 
PACKAGING CELLS 
A paper to be submitted to Human Gene Therapy 
Won-Bin Young'-^  and Charles J. Link, JrJ'^  
RUNNING TITLE: Chimeric retroviral helper virus for high vector production. 
ABBREVIATIONS: 
LTR: long temninal repeat MoMLV: Moloney murine leukemia virus 
RCR; replication competent retrovirus MTase: methyltransferase 
VPC: vector producer cell Env: envelope 
KEYWORDS: vector producer cell; genetic instability; gene therapy; retrovirus; DNA methylation; 
retroviral vector; packaging cell; superinfection; retroviral interference; Moloney murine leukemia 
virus. 
 ^Human Gene Therapy Research Institute, John Stoddard Cancer Center, 1415 Woodland Ave., 
Des Moines, lA 50309. ^  Molecular, Cellular and Developmental Biology Program, Iowa State 
University, Ames, lA 50011. *To whom reprint requests should be sent, (515) 241-8787; Fax: 
(515) 241-8788; e-mail: linkcj@ihs.org. 
81 
ABSTRACT 
Most retroviral packaging cell lines were established by a helper virus plasmid co-
transfected with a separate plasmid encoding a selection marker. Since this selection marker co­
existed in trans with the helper virus sequence, helper virus gene expression could be inactivated 
by host DMA methylation despite selection for Uie co-transfected selection marker. We found 
previously that DNA methylation could occur in tiie LTR region of helper virus in vector producer 
cells (VPC) up to 2% of tine population per day (Young et al., in preparation). To overcome host 
cell DNA methylation that causes suppression of viral gene expression, we constixicted a 
chimeric retroviral helper virus, pAM3-IRES-Zeo, that consists of MoMLV helper virus and a 
picomavirus intemal ribosome entiy site (IRES) sequence followed by Zeocin^e lection marker 
at the 3 end of env sequence. This pAM3-IRES-Zeo permitted selection for intact and functional 
helper virus in transfected cells without subcloning. By selection with Zeocin™a m ixed 
population of pAM3-IRES-Zeo ti^ nsfected NIH3T3 cells (AMIZ cells) were maintained witii little or 
no DNA methylation of the helper viois 5 LTR. The high level of pAM3-IRES-Zeo gene 
expression resulted in no detectable vector superinfection and high vector titers (2 X10® to 1.5 X 
lO^cfu/ml) after introduction of a reti-oviral vector. After Zeocin™ selection was withdrawn from 
AMIZ cells, methylation of 5 LTR increased from 17% to 36% of tiie population during 67 days of 
continuous culture and became susceptible to superinfection. During this period, gene expression 
of pAM3-IRES-Zeo decreased and vector titer production was reduced to 2 X10"^  cfli/ml. These 
data demonsti^ te an important role of DNA methylation in genetic instability of VPC. Thus, the 
chimeric helper virus design allows establishment of a packaging cell line capable of high vector 
production without cloning procedures. 
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INTRODUCTION 
Our laboratory is interested in the genetic instability of retroviral VPC caused by host cell 
DNA methylation. We previously obsen/ed that extensive DNA methylation could occur in 
LTK0SN.2 VPC of retroviral helper virus sequences in 2% of cell population per day. The DNA 
metiiylation of helper vinjs 5 LTR in LTKOSN.2 VPC correlated with reduced helper virus gene 
expression. These cells therefore had significantiy reduced Env-receptor interference and 
became target cells for vector re-entry (superinfection). The VPC developed increasing genetic 
instability manifest by increasing vector copy numbers within the cells. The decreased helper 
virus gene expression secondary to DNA metinylation dramatically reduced vector titer of VPC 
(53). In order to overcome these observed limitations, we designed a modified retroviral helper 
virus to overcome limitations caused by host DNA methylation. 
Mammalian DNA methyltiBnsferase (MTase) catalyses the ti^ nsfer of a metiiyl group to 
cytosine located 5 to guanosine (CpG dinucleoti'de) and causes epigenetic effects which usually 
involves gene silencing (reviewed in reference 47). Metiiylated CpG dinucleoti'des inactivate gene 
expression by altering DNA confomiation (7, 22, 36) or binding methylated CpG-binding proteins 
(12,23, 38, 39) that impede ti^ nscripti'on. The majority of DNA methylation patterns in 
mammalian genomes are found in retirovirus-related sequences, such as retrotransposons and 
endogenous or exogenous retroviruses (52). Evidence suggests that DNA methylation may act 
as a host defense system against retroviral invasion of the cellular genome (3, 51, 52). DNA 
metiiylation can be triggered by insertion of viral DNA sequence into chromosomes regardless of 
whether tiransfection (2) or viral infection (16,29,45) was used to introduce viral DNA sequences. 
In several other experimental systems, host cell methylation of retiroviral provirus or 
reti-otiransposons has been evaluated. In a ti^ nsgenic mouse model, a retroviral provirus altered 
metiiylation pattern witiiin 1 kb of tiie reti-oviral integration site and the provirus was metiiylated 
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leading to an inactivaton of transcription (17,18). Sequences of small interspersed repetitive 
elements contained in the rat a-fetoprotein promoter region were associated with increased DNA 
methylation and decreased downstream reporter gene expression (11). Reduction of host DNA 
methylation leads to amplification and retrotransposition of KERV-1 (kangaroo endogenous 
retroviral element-1) and xenologous recombination of chromosomes in interspecific mammalian 
hybrids of tiie Australian wallaby (41). Interestingly, retix)viruses may benefit fixjm host DNA 
methylation as well. HIV-1 infection may induce host DNA methylation activity and, as a 
consequence, the promoter region of gamma interferon was downregulated by DNA methylation 
(29). This might in theory alter tiie balance of cytokines and reduce immune sun/eillance (28,29). 
The Inactivation of HIV-1 or HTLV-1 gene expression by host DNA methylation of viral LTR 
regions may also induce latency of HIV-1 or HTLV-1 infection (1, 28,44,45). 
These prior experiments did not evaluate DNA methylation of helper virus 5 LTR in VPC. 
Many commonly used retroviral vector packaging cell lines were established by co-transfecb"on of 
two plasmids, one plasmid contains a helper virus genome and the other encodes a drug 
selection marker (26, 31-33). In this co-b^nsfecti'on system, selection for dnjg resistance does 
not require active helper virus gene expression, so tine 5 LTR promoter region can be silenced by 
DNA methylation. In tiie current study, a chimeric helper virus, pAM3-IRES-Zeo'^  was designed 
containing an IRES sequence of tiie encephalomyocarditis virus (ECMV) (19), a member of 
picomaviruses (43), and a Zeocin™resistance gene (Zeo") (9) to allow selection against DNA 
methylation that might occur in the helper virus 5 LTR region. 
For translation of mosteukaryoti'c mRNAs, ribosomes scan mRNAfi-om tine 5 cap 
sequence until an initiation codon is reached. In contiBst, in picomavirus mRNA, ribosomes 
initiate translation by an altemative mechanism tiiat involves internal initiation ratiner than 
scanning. The IRES sequences of picomavirus enable ribosomes to bind in a cap-independent 
fashion and start ti^ ansiation at the next AUG codon downsti'eam (20). Ligation of IRES sequence 
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followed by Zeo"" at the 3 end of env gene pemnits the translation of helper virus open reading 
frames and a selection marker from the same mRNA (Rg. 3). Selection with Zeocin'^ fel iminates 
cells witii metiiyfated helper vinjs 5 LTRftiom the population. This design should ensure more 
stable helper virus gene expression which would increase virion production and create sufficient 
Env-receptor interference to prevent superinfection. The prevention of superinfection may in turn 
reduce RCR formation (34, 35). One additional advantage is that pAM3-IRES-Zeo allows for 
establishment of packaging cell lines within a shorter time period. This advantage might be criti'cal 
when making human VPC from a primary cell culture or stem cells to avoid immune rejection (48, 
49) while transplantation of VPC into patients is necessary for continuous gene ti^ nsfer (42). (W.-
B. Young is a doctoral candidate at Iowa State University, and this work represents partial 
fulfillment of dissertation requirement) 
MATERIALS AND METHODS 
Construction of helper virus pAM3-IRES-Zeo and LEIN vector. An IRES sequence of 
ECMV was isolated from the LXIN retrowral vector (Clontech, Palo Alto, CA) witii Nsil and Psfl 
digestions and tiien inserted into a Psfl-linearized pZeoSV mammalian expression vector 
(Invifrogen, Carishbad, CA) immediately 5 of EM-7 prokaryoti'c promoter/Zeodn™ resistance 
gene (Zeo )^ to create an IRES-Zeo expression cassette. This plasmid was named pIRES-Zeo-
SV40. San digestion on plRES-Zeo-SV40 deleted tiie SV40 promoter and downsfream 
polyadenylation signal to generated pIRES-Zeo. A 2.8-kb fragment, consisting of IRES-Zeo 
expression cassette, SV40 polyA signal, bacterial replication origin (ColEI Ori) and phage 
replication origin (F1 Ori), was excised from plRES-Zeo-SV40 by sequential steps, including EagI 
digestion, freatment with Klenow enzyme (GIBCO BRL, Life Technology Co., Gaithersburg, MD) 
to fill in the EagI restiiction site, and Xbal digestion. To construct pAM3-IRES-Zeo, an 
amphotropic helper virus pPAM3 (31) (kindly provided by A. Dusty Miller, Fred Hutchinson 
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Cancer Research Center, Seattle, WA) was digested by Hpal at 3 end of env gene and Nhe\ at 
5 end of LTR to delete the C0IEI On and amplcilin resistance gene (AmpR). This deleted region 
was replaced with the 2.8-kb IRES-Zeo-containing fragment described above (Rg. 3). The 
resulting chimeric helper virus plasmid, pAM3-IRES-Zeo, allows selection with Zeocin™ in 
bacterial culture and mammalian cells. 
The LEIN retroviral vector carrying an enhanced green fluorescent protein (EGFP, (6, 
10), Clontech, Palo Alto, CA) reporter gene was constructed by replacing the SV40 promoter-
neomycin phosphotransferase gene (Neo  ^cassette of pLESN (27) with a 1.4-kb IRES-Neo"^  
cassette, excised from pIRES-Neo by A/ael and Afe/l digestions. 
Cell culture and transfection. Cell cultures were maintained in Dulbecco modified Eagle 
medium (DMEM; GIBCO BRL, Life Technology Co., Gaithersburg, MD), 10% fetal calf serum 
with 5% CO2, at 37°C. The subclones of LTKOSN.2 VPC were obtained by limiting dilution of 
parental LTKOSN.2 VPC onto two 96-well plates from previous study (53). Helper virus and 
vector gene expression, DMA methylation status and vector production ability in these subclones 
have been previously characterized. Transfections of pAM3-lRES-Zeo into these LTKOSN.2 
VPC subclones and/or NIH 3T3 tk- cells to produce AMIZ packaging cells were perfomied using 
Fugene 6™ Transfection Reagent (Roche Molecular Biochemlcals, Indianapolis, IN). Prior to 
tiransfection, pAM3-IRES-Zeo plasmid was linearized by BspHI digestion and 6 to 10 |ig of 
pAM3-IRES-Zeo was then transfected to each well in 6-well plates. Selection with Zeocin™(350 
lag/ml, Invitrogen) started 48 hr after ti^ nsfection and continued for at least two weeks. 
Transfection of LEIN vector into the AMIZ cell pool and GP+E86 packaging cells (26) (kindly 
provided by Artiiur Bank, Columbia University) was perfomned by using DOTAP Liposomal 
Transfection Reagent (Roche Molecular Biohemicals) witii 5 |ag of LEIN plasmid for each well in 
6-well plates. Selection with G418 (1 mg/ml; GIBCO BRL, Life Technology Co.) started 48 hr 
after transfection and continued for two weeks. 
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Retroviral infection, superinfection and titer assays. Titer assays were performed 
using stendard procedures. Supematants collected from pAM3-IRES-Zeo-transfected LTK0SN.2 
VPC subclones were diluted in 10-fold serial dilutions to transduce NIH3T3 tk{-) cells [American 
Type Culture Collection (ATCC) CRL1658], A375 cells (ATCC CRL1619, human melanoma) and 
IGROV cells [human ovarian cardnoma (50)], which were plated at 1 X10® cellsA/vell in 6-well 
plate witiilO ^ g/ml of protamine sulfate. Twenty-four hours after ti^ nsduction, cells were selected 
in medium containing G418 (1 mg/ml) for 10-14 days. Titers were calculated by multiplying tiie 
number of resistant colonies by the dilution factor. 
To perform superinfection assays on AMIZ cells, supematants containing LEIN vector 
collected from LEIN-transfected AMIZ cells were passed through a 0.4-^ im syringe filter and 
diluted 10-fold and 100-fold. NIH3T3 and PA317 cells were transduced as Env-receptor 
interference positive and negative conti-ols, respectively, along with AMIZ cells. Selection witii 
G418 (1 mg/ml) on tiiese transduced cells started 24 hr after a single exposure to LEIN vector 
and continued for 10-14 days. The number of G418 resistant colonies was used as the index for 
superinfection on PA317 and AMIZ cells. Transduction of a LEIN vector from GP+E86 cells into 
AMIZ cell pool was perfomned as in tiie above superinfection procedure without dilution of 
supematants. 
RNA analysis of helper virus and vector gene expression. Total cellular RNA was 
isolated from ti^ nsfected cells and VPC by using RNAeasy kit (Qiagen Inc., Valencia, CA) and 
subjected to Northern blot analysis on a 1% agarose-0.4M formaldehyde gel. Vector ti^ nscripts 
were detected by Neo''probe and helper viral transcripts were detected by a 1.4-kb env probe, 
which was digested from pPAM3 by X/70I. Human glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) cDNA probe was used to demonsti:Bte similar RNA loading. 
DNA Methylation analysis. In AMIZ cells ti^ nsfected witii LEIN vector, the methylafa'on 
status of provirus and vectors at the Smaf site in the 5 LTR as determined by digestion of 
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genomic DNA with Dra\ and EcoRV to reduce the DNA fragment size. The DNA was then 
precipitated with ethanol, re-dissolved in sterile water and divided into two equal portions, one of 
which was subjected to methylation-sensitive Smal restriction endonuclease digestion. The 
Southern blot membrane was hybridized wttii a 428-bp fragment of gag sequence {Pvu\\/Dra\) 
fixDm pPAM3 to detect helper virus, a 273-bp EcoRI/EcoRV Augment of HSVtfc sequence for 
LTKOSN vector, and a GFP probe to detect LEIN vector. Densitometric analyses were 
performed with a Hoefer Densitometer GS300 (Hoefer Sdentific Instruments) to measure the 
relative densities of Smal-sensitive band compared to Dral/EcoRV band. Due to interference 
from endogenous retroviral elements, the fraction of Smal methylation in 5 LTR was calculated 
as one minus tine intensity ratio of the Smal sensitive band (1.5-kb) divided by Dral/EcoRV band 
(1.8-kb) as depicted in Rg. 6. 
In AMIZ cells, no interference from eithervector or endogenous reti-oviral sequences was 
present. The DNA methylation status of 5 LTR region of pAM3-IRES-Zeo was determined by 
digesting genomic DNA witii EcoRV, Ss£ll and Smal. If methylation occurred at the Smal site, a 
608-bp fragment would be excised instead of a 348-bp fragment when probed with a 261-bp 
fragment excised from pAM3-IRES-Zeo by Kpnl and AMI digestions. The degree of DNA 
methylation was calculated as the intensity ratio of tiie Smal insensitive band (608-bp) divided by 
the sum of tiie intensity of tills 608-bp fragment and Smal sensitive fragment (348-bp) as 
depicted in Rg. 3. 
RESULTS 
Construction of a chimeric retrovirai helper virus with IRES and selection marker 
to allow direct selection of helper virus gene expression. We previously determined that 
DNA methylation occurred in 2% of the cell population per day within 5 LTR region of helper virus 
to inactivate helper virus gene expression in VPC (53). To eliminate methylated helper virus 
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SLTRfrom packaging cell population, a chimeric retroviral helper virus, pAM3-iRES-Zeo (Rg. 1), 
was constructed. The pAM3-IRES-Zeo construction allows Zeodn™ selection of cells with 5 LTR 
promoter function, since helper virus and Zeo"^  gene expression are transcribed fi'om the 5 LTR 
promoter (Rg. 1B). The selection with Zeocin™ maintains cells that also express helper virus and 
therefore counteract DMA methylati'on effects. Packaging cells based on this pAM-IRES-Zeo 
helper virus should maintain high titer production. Secondarily, tfie evaluation of tiiese pAM3-
IRES-Zeo ti^ nsfected cells witii or without Zeodn™ selection allows study of metiiylati'on of 
helper virus 5 LTR and helper virus gene expression over time. 
Analysis of chimeric pAM3-iRES-Zeo vector packaging ability. To test tine packaging 
ability of pAM3-IRES-Zeo helper virus, pAM3-IRES-Zeo was ti^ nsfected into three individual 
subdones of LTK0SN.2 VPC. The pPAM3 helper virus gene expression in tinese tiiree 
LTKOSN.2 VPC subclones #1, #3 and #5 (Rg. 2A, lanes 4-6), were inactivated by DNA 
methylati'on with impeded vector production ability (Table 1)(53). However, LTKOSN (4.0-kb) and 
ALTKOSN (2.8-kb) vectors in these subdones were still tinanscribed (Rg. 2B, lanes 4-6) and no 
significant DNA methylati'on of these vectors was observed (53). This indicates tiiat a key 
limitation of vedor production in LTKOSN.2 VPC subdones is the lack of helper virus gene 
expression. Rescue of LTKOSN and ALTKOSN vedors from these three subclones was 
perfonned by transfection of pAM3-IRES-Zeo followed by two weeks of Zeocin™ selection. This 
restored high level of vedor production was shovwi by titer analysis on human IGROV ovarian 
cardnoma, human A375 melanoma and murine NIH3T3 tk- target cells. The titers ranged fi'om 
1.6 X10  ^to 4 X10® colony fomriing units (cfu)/ml (Table 1). In addition, tills increased packaging 
activity witin pAM3-IRES-Zeo resulted in a reduction of retained LTKOSN and ALTKOSN vedors 
inside VPC when evaluated by Northern blot analysis (Rg. 2B, lanes 7-9). 
Analysis of gene expression in pAM3-IRES-Zeo transfeded LTKOSN.2 VPC subclones 
demonstiBted significantiy greater helper virus gene expression compared to pPAM3 in PA317 
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packaging cells and parental LTKOSN.2 VPC (Rg. 2A). In addition to env'transcripts, only one 
jsopulation of unspliced helper virus (gagiX)f-env-\RES-Zeo) was detected in pAM3-IRES-Zeo 
transfected cells, which indicates that the Integration of pAM3-IRES-Zeo should be intact in 
transfected cells after selection. In contrast co-transfection of pPAM3 without direct selection for 
pPAM3 gene expression but other selection marker in trans could result in randonnly interrupted 
pPAMS for integration. This was represented by two more ti^ nscripts of lower molecular weights 
detected in PA317 and LTKOSN.2 VPC (Rg. 2, lanes 2 and 3) (53). Overall, tiiese results 
demonstrate that enhanced and maintained helper virus gene expression can be obtained in 
pooled packaging cells when pAM3-IRES-Zeo is used to allow Zeocin™ selection witiiout the 
need to perform time-consuming cell subcloning. This implies a potential use of pAM3-IRES-Zeo 
to establish new packaging cells from other cells such as human primary cells. 
pAM3-IRES-Zeo transfected cells provides a model to study DNA methyiation of 
retroviral sequences. DNA methyiation In mammalian cells is site-dependent within the genome 
(14). Therefore, a mixed population of pAM3-IRES-Zeo ti^ nsfected cells would be required to 
study DNA methyiation of helper virus 5 LTR to minimize the effects of positional interference. A 
pool of packaging cells, AMIZ, was established by transfection of pAM3-IRES-Zeo into NIH3T3 
tfc-cells and selection with Zeocin™ without subcloning. To allow DNA methyiation to occur, AMIZ 
cells were released from Zeodn™ selection for one month and then placed in continuous culture 
witii or without Zeocin™ selection for 78 days (about 10 passages). DNA methyiation and gene 
expression of pAM3-IRES-Zeo were examined at 15,54, and 78 days after being released from 
selection. Over the first 54 days of cell culture period, DNA methyiation of 5 LTR was increased 
from 8% to 19% and by Day 78 reached 61% (Rg. 3). The DNA methyiation rate of helper virus 
5 LTR averaged 0.7% of population per day during 78 day period. AMIZ cells witii continued 
Zeocin™ selection did not exhibit any detectable DNA methyiation (Rg.3). This demonsti^ tes tiie 
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effectiveness of daig selection to eliminate methylated pAM3-IRES-Zeo fl-om the pooled AMIZ 
population. 
Retroviral superinfection is bloci(ed by enhanced helper virus gene expression. To 
study the effect of Zeodn™ selection on AMIZ cells, we analyzed gene expression of pAM3-
IRES-Zeo in AMIZ cells from the above experiment Gene expression of pAM3-IRES-Zeo in 
AMIZ cells with constant Zeocin™ selection showed a 2-fold increase compared to AMIZ cells 
without selection on Day 15 and a 4-fold increase on Days 54 and 78 (Rg. 4). In contrast, pAM3-
IRES-Zeo gene expression in AMIZ cells withoutZeodn^selection declined overtime (Rg. 4, 
lanes 3, 5 and 7). Continuous Zeodn™ selection may have selected integration sites that are 
highly transcriptionally active and tiiat have less DMA metiiylati'on activity (5,22). 
We next directiy detemnined whether decreased pAM3-IRES-Zeo gene expression 
reduced Env-receptor interference and increased vector superinfection. The susceptibility to 
superinfection was measured by exposing AMIZ cells with or without Zeodn™ selection from the 
above experiment to amphoti-opic LEIN vector supematants followed by G418 selection. G418 
resistant colony number obtained fi'om AMIZ cells with continued Zeocin™ selection was 
reduced from 2.3 X10  ^on Day 15 to no superinfection observed on Days 54 and 78 (Table 2). In 
contrast, G418 resistant colonies obtained from AMIZ cells without Zeodn™ selection ranged 
from 1.2 X10  ^to 5.6 X10 .^ These results demonstrate tiiat increased gene expression of helper 
vims correlates with reduced susceptibility to superinfection. 
High level of vector production was maintained by Zeocin™ selection. To study 
vector production ability of tinis AMIZ cell pool, we transfected LEIN vector into AMIZ cells 
followed by G418 selection to establish a VPCfor titer assay. Zeocin™ selection was temporally 
withdrawn from AMIZ ceil culture during the first tiiree weeks of G418 selection after ti^ nsfection 
with LEIN vector. Titer obtained fi-om tills newly established uncloned population of AMIZ cells 
was 3.5 X10® cfti/ml, which is 100-fold higher than the titer observed firom a mixed population of 
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PA317 transfected with LEIN vector (4 X10  ^cfu/ml). In addition. AMIZ cells were transduced with 
LEIN vector collected from LEIN-transfected GP+E86 cells and an improved titer of 9 X10® 
cfii/ml was obtained from a mixed cell population. To investigate whether selection with both 
Zeocin™ and G418 would adversely affect vector production, LEIN transfected AMIZ cells were 
evaluated 56 (8 passages) and 67 days (10 passages) after transfection. Titers obtained from 
AMIZ cells transfected with LEIN and placed under continuous selection with Zeocin™ and G418, 
were maintained between 2 X10® to 1.5 X10  ^cfu/ml (Table 3). In contrast, titers obtained from 
the same AMIZ cells transfected with LEIN but not maintained with G4-18 and Zeocin™ selection 
decreased to between 2 to 4 X10"* cfu/ml. The reduced titer correlated with a significant decrease 
of both helper virus and vector gene expression (Rg. 5). 
DNA methylation status of 5 LTRs of helper virus and vector were significantiy increased 
in AMIZ cells transfected with LEIN vector and cultured without either G418 or Zeocin™ selection 
(Rg. 6). This increased methylation corresponded to decreased vector titer (Table 3) and 
significantiy reduced gene expression of helper virus and vector (Rg. 5). The DNA methylation of 
helper virus 5 LTR increased from 17% (Day 0) to 30% and 36% by Days 56 and 67, 
respectively. The average DNA metiiylati'on rate of helper virus 5 LTR in AMIZ cells transfected 
with LEIN was estimated as low as 0.3% of tiie cell population per day during 67 days of 
continuous cell culture. In contrast DNA methylation was not detected in AMIZ cells transfected 
with LEIN vector and placed under continuous G418 and Zeocin™ selection. No detectable DNA 
methylation occurred of LEIN vector on Day 0 (Rg. 6B, lanes 3 and 4) while 17% DNA 
methylation of 5 LTR helper virus was detected (Rg. 6A, lanes 3 and 4). This may be secondary 
to the timing of G418 and Zeodn™ selection. AMIZ cells transfected with LEIN vector were 
placed under G418 for three weeks to select for LEIN-positive population and Zeocin™ selection 
was not applied until Day 0 in tiie experiment 
92 
DISCUSSION 
The experimental model described in this study demonstrates an approach using a 
retroviral helper virus combined with picomavirus (RES sequence and a selecbon mariner gene 
that allows efficient elimination of methylated helper virus from packaging cell populations. This 
strategy of using drug selection maintained high levels of helper virus gene expression and high 
titer vector production (1.5 X10  ^cfu/ml) from populations of VPC without subcloning. The 
presence of greater Env-receptor interference blocks vector superinfection and may reduce other 
potential problems with retroviral vectors such as RCR formation. 
The potential application of this chimeric helper virus to gene therapy might allow 
packaging cells to be established fi"om primary cell culture with less time and without subcloning. 
Transfection of the pAM3-IRES-Zeo into cells followed by selection for positive populations takes 
only two weeks or less, depending on transfection efRdency. This is particulariy useful for 
transplantation of VPC into patients (42) for continuous in vivo gene transfer without the immune 
elimination of murine VPC and virions (48,49). Several stijdies have aimed to establish a 
retroviral packaging cell line by using other viral vectors, such as adenovirus (4, 8,25) and 
herpes simplex virus (46), to import retroviral helper virus genome into target cells in vivo or ex 
vivo. These approaches have significant limitations such as immunogenicity of tiie additional 
virus and direct cytotoxicity to the infected cells (13, 37). Since tine transferred helper virus 
sequences are not integrated into chromosomes, these systems generally have lower and 
unstable titers secondary to a loss of transferred helper virus. In this study, we demonsti^ te that 
the titer of pooled population of pAM3-IRES-Zeo-transfected cells, AMIZ cells, was maintained 
between 3.5 X10® to 1.5 X10' cfu/ml for at least 67 days. These titers are comparable to 
reported titers fiiom individually cloned VPC, which generally ranged from to 10  ^(30). 
Transducing LEIN vectors Into AMIZ cells instead of transfection also resulted in a uncloned 
population of VPC with high titer production (9X10® cHi/ml). 
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The selection of transfected cells (AMIZ cells) with Zeodn™ to maintain pAM3-IRES-Zeo 
gene expression eliminated DMA methylation firom AMIZ cells and may also select cells with 
pAM3-!RES-Zeo helper virus integrated in optimal and active chromosomal regions. Ratios of 
pAM3-IRES-;&o gene expression in selected AMIZ cells compared to non-selected AMIZ cells 
were about 4:1 on Days 54 and 78. The percentage of 5 LTR methylation was 0% in cells under 
continuous selection and 19% (Day 54) and 61% (Day 78) in cells without selection. The 
differences in vector titers were more dramatic with a 10OO-fold greater, 1.5X10' cfu/ml, Day 78, 
in LEIN-transfected AMIZ cells under continuous selection, compared to 4 XIC* cfu/ml. Day 78, 
in cells witiiout selection. This dramatic difference probably reflects the fact that structural 
proteins of viruses function as multi'mers (15). Therefore, the fomnation of multimers occurs in a 
sigmoid dose-response fashion, rather than a linear dose-response to protein concentration that 
correlates more directiy with helper virus gene expression. To maintain efficient Env-receptor 
interference and active viral production, a threshold level of helper virus gene expression is 
required. In reti^ ovirus infection, this threshold level of gene expression is established by the 
accumulation of sufficient copy number of virus through superinfection until efficient Env-receptor 
interference is achieved and maintained (40). In our study, the threshold level of helper virus 
gene expression was achieved by Zeocin™ selection rather than increasing tiie copy number of 
helper virus. When selection pressure was released, superinfection was observed after helper 
virus gene expression declined. These results support a conclusion that continuous selection of 
helper virus in VPC might enhance Env-receptor interference and reduce tiie possibility of RCR 
fomiati'on. 
For continuous virus production without interfering witii host cell growth and 
differentiation, reti-oviral gene expression has to be regulated at a level just sufficient in retrovirus 
infected cells. Increased levels of viral RNAs and proteins in infected cells can cause cytopathic 
effects, usually at the cost of cell death, by intenxipti'ng tiie production ortiBnslation of host 
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mRNA (47) (for a review see reference 46). Althougin we obsen/ed that AMIZ cells under 
continuous selection did proliferate more slowly than AMIZ cells without selection, under 
continuous selection for 67 days, AMIZ cells transfected witii LEIN vector proliferated without 
difRculty (data not shown). 
We did not attempt to select for pPAM3 gene expression by drug selection against the 
HSVtk selection marker plasmid co-transfected into PA317 cells. This approach is unlikely to be 
successful since the selection marker plasmid is separate firom pPAM3. An alternative approach 
to reverse methylation is ti'eatment with 5 -aza-cyti"dine (5-aza-C) to reverse DNA metiiylation (21, 
24). In our previous experiments, we found that only a minor portion of pPAMS helper virus 
expression could be restored by 5-aza-C (53). Treatment with 5-aza-C does not specifically 
reverse helper viais DNA metiiylation, but inhibits Uie cellular DNA methyltransferase and causes 
cytotoxicity to treated cells (21). The data from this study suggest that a combination of helper 
virus and IRES sequences witii selectable markers is a viable option to eliminate host DNA 
methylation of helper virus from VPC. 
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TABLE 1 .Titer of LTKOSN.2 VPC subclones before and after 
transfection of pAM3-IRES-Zeo helper virus 
Target cells 
pAMS-IRES-Zeo NIH3T3 A375 IGROV 
Subclone #1 + 1-1 X10^ 
1 XIO"* 
1 X 10'' 
2X 10° 
1 X10^ 
0 
Subclone #3 
+ 5X10® 
0 
5.5X10® 
0 
4X10® 
0 
Subclone #5 
+ 1.6X10^ 
0 
5X10® 
0 
4X10® 
0 
TABLE 2. Increased resistance of superinfection by Zeocin 
selection 
Target cells 
AMIZ 
NIH3T3 PA317 No Selection Selection 
Day 15 7X10® 3.2 X 10"^ 4.3 X 10^ 2.3 X lO"* 
Day 54 6X10"^ 1 XIO'^ 1.2 X 10=^ 0 
Day 78 5X10® 1.9X10"^ 5.6X10^ 0 
TABLE 3. Titer of AMIZ cells transfected wrth LEIN with 
continuous drug selection 
Day 0 Day 56 Day 67 
Selection No Selection Selection No Selection 
3.5X10® 2X10® 2X10"^ 1.5X10^ 4X10"^ 
FIG. 1. Constmct'on and cap-independent translation nnechanism of chimeric pAM3-
IRES-Zeo helper vims. (A) For details see Materials and Methods. Briefly, a 2.8-kfa fragment 
including [RES-Zeo expression cassette, a SV40 polyA signal sequence, bacterial replication 
origin (C0IEI On) and phage replication origin (F1 On) was exdsed from pIRES-Zeo. The C0IEI 
Ori and ampicilin resistance gene region (AmpR) of pPAM3 were replaced with above 2.8-kb 
IRES-Zeo-containing fiBgmentfirom pIRES-Zeo. The EM7 prokaryoti'c promoter located at 5 end 
of Zeo"^ gene permits selection for pAM3-IRES-Zeo in bacterial. (B) Genomic RNA of MoMLV 
contained two internal stop codons at 3 ends of gag and pol genes thattemninate cap-dependent 
translation and allow appropriate ratios of viral structural proteins. In pAM3-IRES-Zeo derived 
transcripts, ribosomes also recognize IRES sequence and initiate translation from the first ATG 
codon of Zeo*^ downstream of IRES sequence. A portion of genomic RNA is spliced into env 
transcripts tiiat are translated in cap-dependent mechanism. SD, splicing donor; SA, splidng 
acceptor. 
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Hpai 
SV40 pA 
Anip(R) 
pPAM3 
10668 bp S*LTR 
SV40 pA 
EM7 
piRES-Zao 
3455 bp IRES 
FI Oft 
Xbst 
SV40pA 
CGIEI Oft 
pAM3-IRES-Zao 
10743 bp 
B pAM3-IRES-Zeo 
SD SA 
L I U IRES Zeo 
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UAG UAAUAG 
H • AAA 
FIG. 2. Gene expression of pAM3-IRES-Zeo and vectors in LTK0SN.2 VPC subclones. 
(A) Northern blot analysis of cellular RNA extracted from pAM3-IRES-Zeo transfected LTK0SN.2 
subclones hybridized with env probe. Unspliced MoMLV transcript (gag-po/-env-IRES-Zeo) and 
spliced RNA (env-IRES-Zeo) were significantly greater than pPAM3 gene expression, which only 
exhibited spliced env transcripts. (B) Gene expression of LTKOSN and ALTKOSN vectors. 
Hybridization of the same Northern blot membrane with Neo"^ probe to detect RNA transcripts of 
LTKOSN (4.0 kb), ALTKOSN (2.5 kb) expressed fiom 5 LTR and a Neo"^ transcript (1.2 kb) 
expressed from the Internal SV40 promoter. Fewer vector transcripts were retained In pAM3-
IRES-Zeo transfected cells since transcripts were packaged into virions. (C) Hybridization of the 
same Northem blot membrane with human GAPDH cDNA probe demonstrates fairiy equivalent 
RNA loading. 
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LTK0SN.2 
sub-clones 
pAM3-(RES-Zeo 
transfection 
Helper 
Virus 
B 
Vector 
— unspliced 
— env-IRES-Zeo 
— env 
LTKOSN 
ALTKOSN 
neo 
GAPDH 
1  2 3 4 5 6 7 8 9  
FIG. 3. DNA methylation of helper virus S LTR over time with and without Zeocin™ 
selection. (A) Schema of pAM3-IRES-Zeo helper virus showing restriction enzyme sites and 
the probe used for the methylation analysis. B, SsfEII; E, EcoRV; S, Sma\: AAA, SV40 poly 
(A) signal. Drawing is not to scale. (B) Genomic DNA Southern blot membrane was probed 
with a 261-bp fragment excised from pAM3-IRES-Zeo with Kpn\ and Afl\\ digestions. If 
methylation was present at the Smal site, a 608-bp fragment would result instead of a 348-
bp fragment The degree of DNA methylation was calculated as the intensity ratio of Sma\ 
insensitive band (608-bp) divided by the sum of the intensity of this 608-bp band and Sma\ 
sensitive fragment (348-bp). 
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A 
E S B 
r-J—L I , , I LTR H 1 I P9l r env IIRES I Zeo I AAA 
608 bp 
348 bp 
• LTR/gag probe 
B CO o ^ 
Zeocin 
Selection 
1-
I I I 1 
- - - + - + 
FIG. 4. The effectiveness of Zeocin™s election on helper virus gene expression in 
AMIZ cells overtime. (A) Unspliced MoMLV transcript (gag-po/-env-IRES-Zeo) and spliced 
RNA (env-IRES-Zeo) were detected by an env probe In cellular RNA extracted from AMIZ 
cells with and without continuous Zeocin™s election on Days 0, 15, 54 and 78. (B) 
Hybridization with GAPDH cDNA probe demonstrates the relative RNA loading. 
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DayO Day 15 Day 54 Day 78 
Zeocin 
selection 
unspliced 
GAPDH 
FIG. 5. Gene expression of pAM3-IRES-Zeo helper virus and LEIN vector in AMIZ 
ceils transfected with LEIN vector. (A) Northern blot analysis of cellular RNA extracted from 
AMIZ cells transfected with LEIN vector evaluated at passage 3 (day 0, lane 1) and on days 
56 and 67 (lanes 2-5) by hybridization with env probe. Zeocin^ n d G418 selection resulted 
in greater levels of unspliced MoMLV RNA transcript {gag-pol-env-lRES-Zeo) and spliced 
RNA transcripts (env-IRES-Zeo). (B) The level of LEIN vector was also greater In AMIZ cells 
under Zeocin ™and G418 selection. (C) Re-hybridization with GAPDH cDNA probe was 
used to demonstrate fairiy equivalent RNA loading. 
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FIG. 6. Drug selection eliminates DNA methylation of helper virus and vector from 
VPC population. Genomic DNA extracted from AMIZ cells transfected with LEIN vector with 
Zeocin™ and G418 or without drug selection on days 0 (lanes 3 and 4), 56 and 67 (lanes 5-
12) were first digested with Oral and EcoRV and divided into two equal portions. One portion 
was subjected to methylation-sensitive Smal restriction endonuclease digestion and the 
other without Smal digestion. (A) Hybridization of gag DNA probe to detect helper virus 5 
LTR. Smal digestion reduced the 1.8-kb band (even numbered lanes 4-12) to 1.5-kb (odd 
numbered lanes 3-11). DNA from NIH3T3 cells was used to show the presence of 
endogenous retroviral elements (lanes 1 and 2). Since a 1.8-kb band was generated from 
endogenous retroviral element after Smal digestion (lane 1), the values for Smal resistance 
were measured by densitometry as the relative intensities of the 1.8-kb bands without Smal 
digestion, and 1.5-kb bands after Smal digestion. (B) GFP DNA probe was used to detect 
the 5 LTR of LEIN vector. Smal digestion reduced the 3.7-kb fragment to 3.4-kb, 2.7-kb and 
2.4-kb fi'agments dependent upon the methylation status of Smal site In LEIN vector. (C) A 
0.68-kb DNA fragment digested from gag gene of pPAM3 by Bs{K\ was used as a probe to 
detect a 1.2-kb band of endogenous retroviral element to demonstrate relative loading in 
paired Smal+/- digestions. (D) Schema of the helper virus and vectors showing the locations 
of restriction enzyme sites and probes used for methylation analysis. B, 8sO<l, D, Oral, E, 
EcoRV; 8, Smal; AAA, SV40 poly (A) signal. Drawings are not to scale. 
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Helper virus pAM3-IRES-Zeo LEIN vector 
E E S  D  D  S  E  E E S  8  E E S  
1 gag' I ' Ul I ' snv ^|'"^V^°Iaaa hrRT-rgSPPVi^  Neo Klt^ 
——— 1-8 kb 3.7 kb 
1.5 kb 3.4 kb 
• probe 2.7 kb 
2.4 kb 
GFP probe 
B CO I— CO 
2 
111 
g Day 56 Day 67 
< Zeo/G418 Unselected Zeo/G418 Unselected 
% Smal-
Resistance 
17% 0% 30% 0% 36% 
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ABSTRACT 
The superinfection of retroviral vectors into vector producer cells (VPC) is the major 
source of reverse transcriptase (RT) that may results in replication-competent retrovirus 
(RCR) formation. PG13 packaging cells are based on murine NIH3T3 cells and generate 
pseudotyped retroviral virions containing gibbon ape leukemia virus (GaLV) Env proteins to 
improve gene transfer into hematopoietic cells. PG13 does not express GaLV receptor on 
cell surface and therefore is not susceptible to superinfection of its own pseudotyped GaLV 
vectors. This is considered an advantage for PG13 cells. In this report, we found evidence of 
intracellular retrotransposition of retroviral vectors in PG13. This finding suggests that the 
potential of RCR formation might occur inside PG13 cells despite a lack of retroviral vector 
superinfection. In this study, PG13 was transfected with a vector containing a neomycin 
selection marker which functions only after the intron sequence is excised during 
retrotransposition. The ratio of intracellular retrotransposition was determined by the 
presence of G418-resistant colonies and was calculated as high as 1 x 10 and 3.9 X 10'^  
events per cell in PG13 and NIH3T3 cells expressing a gag-po/construct, respectively. In 
contrast, superinfection of this vector into PA317 occun-ed at 5.1 x 10 events per cell. A 
complementary study of serial deletion mutants of MoMLV on NIH3T3 cells expressing this 
retroviral vector demonstrates that the RT activity required for retrotransposition of retroviral 
vectors originates from the intracellular particles of helper virus within the VPC. These 
results indicate that retroviral vectors frequently replicate as retrotransposons in murine VPC 
regardless of the presence of the Env protein. Demonstration of endogenous reverse 
transcriptase (RT) activity in VPC suggests the potential for RCR formation during 
retrotransposition of vectors without superinfection. 
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INTRODUCTION 
The presence of RCR is a key biosafety issue when using retroviral vectors in gene 
therapy applications. The formation of RCR has been shown to occur by abnormal template 
switches between helper virus and retroviral vector sequences during reverse transcription 
(32, 41). Therefore, the prevention of RCR outbreak from VPC may require attempts to 
block or decrease RT enzyme activities inside of VPC. 
There are two categories of RT enzyme activity inside of VPC. Exogenous viral RT is 
imported into cells by virus infection. In a cultured VPC, the only source of exogenous RT 
enzyme activity would be derived from the re-entry of virions produced by the VPC 
(superinfection of vector). Endogenous RT is a combination of retrovlrus-encoded Pr180^®®' 
or po/gene product of virion particles within the cell (2,18, 33, 38), endogenous 
retroviruses (10, 19) and retrotransposons (12, 16,17). These different sources of 
endogenous RT enzyme activity can result In intracellular retrotransposition activity 
(reviewed In reference 22). 
Exogenous RT activity can be limited by Interference between viral Env proteins and 
viral receptors on the cell surface (Env-receptor interference) (31). The re-infection ratio of 
amphotropic Moloney murine leukemia virus (Am-MoMLV) vector virions on target cells, 
which were previously infected with wild type Am-MoMLV, is as low as 10"^ events per cell 
on rat 208 cells and 10"® events per cell on NIH3T3 cells (26). In contrast to Am-MoMLV re­
infection, intracellular retrotransposition of an Env-defective C-type MoMLV has been 
reported at a higher frequency of 2.7 x 10^ events per cell on feline G355-5 cells (39). 
The retrotransposition pathway of this Env-defective retrovirus includes the 
transcription of provlral vector (e.g. integrated MoMLV-based vector), RNA splicing, reverse 
transcription and re-integration of processed provlral vector (13, 38, 39). This process is 
similar to the other previously described events such as the amplification of endogenous 
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retroviais (10) and retrotransposons (4, 12, 36), and the fonnation of pseudogenes (24, 40). 
Retrotransposition is only observed when cells were complemented with retroviral gag-pol 
genes. This indicates that the RT enzyme activity involved in retrotransposition of retroviral 
vector is derived from gag-pol and pol gene products (38, 39). This proposes a possible 
involvement of immature gag-pol and pol gene products in the formation of RCR in VPC 
without superinfection of vector. 
A specific interaction between core proteins and Env is dependent on the N-terminal 
domain of matrix (MA) protein and C-terminal domain of the Env transmembrane subunit (8, 
21). Env proteins have been demonstrated to direct the release of human immunodeficiency 
virus (HIV) (21). This Gag and Env interaction may therefore eliminate intracellular 
retrotransposition of an Env-intact retrovirus by accelerating the release of virion particles. 
To explore the possibility of retrotransposition of retroviral vector in currently used VPC 
irrespective of Env expression, we choose PA317 (25) and PG13 (27) packaging cell lines 
as models to compare with gag-pol transfected NIH3T3 cells. PG13 was established fi-om 
murine NIH3T3 and expresses MoMLV gag-pol genes and a GaLV env gene for packaging 
xenotropic GaLV-pseudotyped vector. Since NIH3T3 cells do not express PiTI receptor for 
GaLV infection, PG13 is not susceptible to superinfection of its own pseudotyped GaLV 
vector (27,44). PA317 is also based on NIH3T3 ceils, but susceptible to infection of 
amphotropic MoMLV vector that it produces. Therefore, RT enzyme activities inside of 
PA317 will be derived from both re-infection of vector virions and endogenous RT provided 
by intracellular virion particles or a cellular source. 
In this study, we compared RT enzyme activity inside of PA317 and PG13 cells with 
a vector containing a neomycin selection marker disrupted by an intron sequence. This 
selection marker only functions after the Intron sequence Is excised during retrotransposition 
that required RT to have occured. This comparison allows an estimation of the ratio of 
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exogenous RT and endogenous RT in a VPC which represents a retrovirus infected cell. 
The difference of RT activity between PG13 and gag-pol transfected NIH3T3 cells can 
therefore reveal the effect of the interaction between GaLV Env and MoMLV core proteins 
on intracellular retrotransposition. The results from PG13 packaging cells indicate a possible 
role of endogenous RT enzyme activity in RCR formation and genetic instability of retroviral 
vectors in VPC. (W.-B. Young is a doctoral candidate at Iowa State University, and this work 
represents partial fulfillment of dissertation requirement) 
MATERIALS AND METHODS 
Plasmid constructions. To construct pELNIH vector, a reporter cassette (neo-int) 
was first isolated from pNeo-!nt (9) (kindly provided by D. Mager at Terry Fox Lab., 
Vancouver, Canada) by BamHl and Sail digestions and then inserted into a retroviral shuttle 
vector, pBabe-Hyg (30) (kindly provided by H. Land, Imperial Cancer Research Center, 
London, UK) for pBabe-NIH (Neo-intron-Hyg) construct. A fragment containing neo-int 
cassettee, hygromycin resistant gene (Hyg""), SV40 promoter and 3 LTR was isolated from 
pBabe-NIH by Eco47lll and Pvul digestions and then subcloned into Eco47lll and Pvul 
digested pELNCX. This pELNCX was previously constructed by digesting pLNCX (28) (a 
kind gift from A. D. Miller at Fred Hutchinson Cancer Research Center, Seattle, WA) with 
Pvul and Seal and then ligation of this pLNCX into Pvull and Pvul digested pREPIO 
(InVitrogen) which contains OriP/EBNA-1 for extrachromosomal replication. 
To generate deletion mutants of MoMLV, a pREP-XC vector was constructed to 
express the mutants. To construct pREP-XC, pREPIO was digested by Xbal and C/al, and 
the restriction sites were filled in by Klenow enzyme (BRL, Life Technology Co.) and self-
ligated to remove Ori/EBNA-1 sequences from pREPIO. Since pREP-XC contains a 
hygromycin selection marker and the mutants carried by this vector become selectable to 
119 
hygromycin in mammalian cell culture. An Env-deletion mutant of MoMLV was first 
constructed byAflWl digestion of pPAM3 (25) (kindly provided by A. D. Miller) and DNA 
fragment ends were filled in by Klenow enzyme followed by Nhe\ digestion to release a 
5" LTR-gag-pol fragment. This 5 LJR-gag-pol fragment was then inserted into PvuW and Nhe\ 
digested pREP-XC after RSV promoter to result in pGP construct, therefore, the gag-pol 
construct is driven by both 5 LTR of MoMLV and RSV promoter (Fig. 3). To construct pAG, a 
gag-deletion mutant, pGP was digested by Mscl and Afl\\ to delete matrix (MA) and capsid 
(CA) open reading frames (ORFs) fi-om the gag gene. After digestion sites were filled in by 
Klenow enzyme and self-ligated, the nucleocapsid (NC) ORF remained intact and in ft-ame 
with first ATG codon of Gag protein and the downstream pol gene. To construct pAP, a 
deletion of RT region, pGP was digested by Stu\ and self-ligated. Downstream IN gene 
remained in frame after the deletion of RT. To construct pAl, an IN mutant, pGP was partially 
digested by C/al and then two extra nucleotides were inserted into the C/al site in IN gene 
by Klenow enzyme fill-in to induce a frame-shift mutation of the IN gene. These mutants 
were sequenced by the Nucleic Acid Facility at Iowa State University to ensure that the 
ORFs are con-ect as anticipated after construction. 
Human L1 retroelement, pJMIOI, is provided by J. V. Moran at U. of Pennsylvania. 
This pJMIOI is selectable (hygromycin) and can replicate in the cell nucleus by an origin of 
replication (OriP/EBNA) from pCEP4 plasmid in mammalian cell culture. This LI .2 element 
(pJMIOI) has been demonstrated with detectable retrotransposition in human Hela cells 
and mouse fibroblast cell line, LTK- (29). 
Cell culture and transfection. Cell cultures were maintained in Dulbecco modified 
Eagle medium (DMEM; GIBCO BRL, Life Technology Co., Gaithersburg, MD), 10% fetal calf 
serum with 5% CO2, at 37°C. Transfections of pJMIOI, pELNIH, MoMLV mutants, pGP, 
pAG, pAP and pAl, were performed by liposome transfection reagent, DOTAP (Roche 
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Molecular Biochemlcals, Indianapolis, IN) with 5 i^g of a single plasmid DNA or 2.5 ng of 
each of two co-transfected plasmids for each well in 6-well plates. Selection with 
Hygromycin B (100 |ig/ml, Roche Molecular Biochemicals) started 48 hr after transfection 
and continued for at least two weeks. Selection with G418 (1 nng/ml; GIBCO BRL, Life 
Technologies) for retrotransposed ELNIH vector was applied for 10-14 days on above 
hygromycin positive cell populations. 
NIH3T3 cells expressing p-galatosidase were established by transfection of pZeo-
SV-LacZ (InVitrogene) and selection with Zeocin™ (350 |ag/ml) for two weeks. A single clone 
was isolated with functional p-galatosidase gene expression. NIH3T3 cells expressing p-
galactosidase were mixed with pELNIH-transfected VPC at a 1:1 ratio and co-cultured for 
one to two weeks before G418 selection. After two weeks of G418 selection, G418-positive 
colonies were rinsed with phosphate-buffered saline (PBS) and fixed for 5 min at room 
temperature in 2% formaldehyde, 0.3% glutaraldehyde in PBS. Following two additional 
rinses with PBS, cells were stained with a chromophore solution containing 0.1% 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside (X-gal) (Promaga, Madison, Wl), 5mM 
K4Fe(CN)6-3H20, 5mM K3Fe(CN)6 and 2mM MgCb in PBS at 37°C for ovemight. p-
galactosidase positive cells were visualized blue under microscopic examination. 
Southern blot analysis of genomic DNA. Total cellular DNA was extracted from 
cell cultures using phenol/chloroform extraction and then dissolved in TE buffer (pH 8.0) for 
ovemight at 55°C (35). To detect the integration locations of retrotransposed vector, 
genomic DNA was digested by Sphl and then evaluated by Southern blot analysis. A 0.35-
kb ft-agment (Neo probe) isolated from pNeo-Int by SamHI and Sphl digestions was used to 
detect the integration sites of retrotransposed pELNIH (Fig. 2A). The same Southern blot 
membrane was also probed with a 0.5-kb ft-agment (PTK probe), isolated from pNeo-Int by 
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Sa/I and Sad digestions, to detect the transfected pELNIH containing intron sequence (1.8-
kb) and retrotransposed ELNIH laci<ing an intron sequence (0.9-kb, Fig. 2A). 
RESULTS 
Construction of a retroviral vector to detect retrotransposition. To detemnine 
whettier retroviral vector could retrotranspose in VPC, we constructed a retroviral vector, 
pELNIH, containing a reporter cassette (neo-int), designed to detect rare retrotransposition 
events (9) (Rg. 1 A). This reporter cassette consists of an antisense copy of an antibiotic 
resistant marker gene (neo), a TK pronnoter with polyoma enhancer, and a polyadenylation 
signal. The neo gene is disrupted by an intron (IVS 2 of y-globin gene) in the opposite 
transcriptional orientation. The reporter gene, neo, will be expressed only after (i) the 
retrotransposable vector has been transcribed, (ii) the intron sequence has been removed 
by RNA splicing and (iii) the spliced transcript has been reverse transcribed and integrated 
into the genome (Fig. 1A). To distinguish the integration of retrotransposed vector from 
transfected vector, this pELNIH was also constructed with an origin of replication 
(OriP/EBNA 1) to allow extrachromosomal replication. Similar cassettes have been 
employed to study the formation mechanism of pseudogenes (24, 40) and detect the 
intracellular transposition of an Env-defective MoMLV retrovirus (13, 38, 39), mouse 
intracistemal A particles (lAP) (4, 5, 12), long interspersed nucleotidic elements (LINE) (16, 
17, 36) and human L1 element (7, 29). 
Retrotransposition of retroviral vector in VPC. To detect retrotransposition in 
VPC without the possibility of vector superinfection, we transfected pELNlH into PG13 
packaging cells and co-transfected pELNIH and pGP, a MoMLV gag-pol construct (see 
Materials and Methods) into NIH3T3 cells. PA317, an amphotropic packaging cell line 
susceptible to superinfection of its own vector, was also transfected with pELNIH for vector 
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superinfection study and to compare with PG13 and NIH3T3 cells transfected with pGP 
(NIH3T3-GP). NIH3T3 transfected with pELNIH was used as a control to determine the 
baseline endogenous RT enzyme activity that has been observed previously with 
pseudogene formation (24, 40). Transfected cells were under hygromycin selection for 14 
days. Hygromycin positive population was expanded for further retrotransposition assay by 
selection with G418 for 10-14 days. The number of G418-res(stant colonies in plated cells 
was used to calculate retrotransposition frequency (Fig. IB). In an initial experiment, 10® 
hygromycin-resistant cells derived fi'om PA317, PG13 and NIH3T3-GP cells were plated in 
medium containing G418 for 10 days, the colonies were too numerous to count. Therefore, 
the cell populations were diluted serially before G418 selection. 
Results fi'om three experiments performed in triplicate (Table 1) showed a relatively 
high frequency of retrotransposition of pELNIH vector in PG13 cells (about 1 event in lO'' 
cells or 1 X 10^ per cell). No G418-resistant colonies were observed in NIH3T3 cells 
expressing pELNIH alone when up to 3 X 10® cells were plated. The retrotransposition 
frequency observed in NIH3T3-GP cells (38.8 X 10^ per cell) was significantly greater than 
that observed In PG13 cells (P< .001, N=9). In PA317 cells that are permissive to 
superinfection, G418-reistant colonies occurred at 5.1 X 10'^  per cell. This frequency reflects 
both exogenous RT and endogenous RT enzyme activity. The relative contribution of 
endogenous RT enzyme activity compared to total RT enzyme activity (exogenous RT from 
superinfection plus endogenous RT) can therefore be estimated by comparing the 
frequencies of G418-resistant colonies in NIH3T3-GP. PG13 with the frequency observed in 
PA317 cells. The ratio of endogenous RT enzyme activity detected in NIH3T3-GP is about 
7.8% of total RT observed in PA317, and, in PG13, the ratio is reduced to 0.2 % of total RT 
in PA317. The reduction of endogenous RT might be contributed by Gag-Env interaction in 
PG13cells. 
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To ensure that G418 resistant foci observed in transfected PG13 and NIH3T3-GP 
cells were not derived from nonspecific transmission of virions from neighboring cells, such 
as cell-to-cell contact infection (23), pELNIH transfected cells were co-cultured with NIH3T3 
cells expressing a p-galactosldase gene. After being co-cultured for one or two weeks, these 
co-cultures were then subjected to G418 selection for retrotransposition. If non-specific 
infection had occurred, p-galactosidase positive colonies would have been observed after 
G418 selection. As anticipated, no blue colonies were observed after X-gal staining of G418 
resistant colonies obtained from co-cultured NIH3T3 expressing p-galatosidase with either 
pELNIH-transfected PG13 or NIH3T3-GP cells. This indicates that these G418 resistant 
colonies authentically resulted from intracellular retrotransposition of pELNIH vector but not 
a result of exogenous RT. In contrast, some p-galatosidase positive G418-resistant colonies 
were obtained from the cells co-cultured with PA317/pELNIH. This demonstrates that the 
infection of ELNIH vector on NIH3T3 cells expressing p-galatosidase did occur (data not 
shown). 
We also calculated the splicing efficiency of this neo-Int cassette by transducing 
human melanoma A375 cells with supernatant collected from PG13 transfected with 
pELNIH, and then selection with either hygromycin or G418. The ratio of G418-resistant 
colonies (spliced vector) and hygromycin-resistant foci (spliced + unspliced vector) was 
42%. The titer of PG13 transfected with pELNIH was approximately about 1X10^ cfu/ml. 
This indicated that only 42% of vector transcripts packaged into virions were spliced. This 
may reflect the vector populations inside of VPC. Since the complication caused by 
sensitivity of different selections and possible altemative splicing of IVS sequence causes a 
defective neo gene (see below), we did not recalculate our previous data of 
retrotransposition events with this splicing efficiency. However, this selection model with a 
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retrotransposible vector couid be a useful tool to study the splicing regulation of HIV 
transcripts or other cellular intron splicing sequences, such as IVS of y-globin in this case. 
Retrotransposed vectors are integrated into the genomic DNA. To determine 
whether these retrotransposed ELNIH vectors were integrated into chromosomes or 
maintained in episomal fomi, individual G418 resistant colonies were isolated from PG13 
cells transfected with pELNIH and NIH3T3-GP transfected with pELNIH. Genomic DNA was 
extracted from each individual clone and digested with Sph\, a DNA methylation-insensitlve 
endonuclease for complete digestion without DNA methylation interference. Southern blot 
analysis was performed with a Neo probe and revealed the integration patterns of 
retrotransposed ELNIH vector (Fig. 2A). Integrated copies of ELNIH within the cell clones 
were resolved in Southem blot analysis. The presence of multiple bands suggested that 
ELNIH vector had retrotransposed into different chromosomal locations within one cell. In 23 
clones isolated from PG13 cells transfected with pELNIH, 16 (70%) clones exhibited 
different integration patterns in Southem blot analysis. The copy number of retrotransposed 
ELNIH vectors ranged from 1 to 6 copies with a mean of 2.3 copies per cell (Fig. 2B). In 
NIH3T3-GP transfected with pELNIH cells, 13 out of 21 colonies (62%) exhibited different 
integration pattems and the copy numbers of retrotransposed ELNIH vectors ranged from 1 
to 8 copies with a mean of 3.2 copies per cell (Fig. 2C). These Southem blot membranes 
were re-probed with a PTK probe (Fig. 2A) to detect both retrotransposed vector and 
transfected pELNIH. Only 3 out of 23 G418-resistant clones derived from PG13 cells 
transfected with pELNIH were detected with the Integrations of both transfected pELNIH (a 
1.8-kb band with intron sequence after Sphl digestion) and retrotransposed ELNIH vector (a 
0.9-kb intronless fragment after Sphl digestion) (Fig. 2B). Only one out of 21 G418-resistant 
colonies derived from NIH3T3-GP transfected with pELNIH exhibted with the integrations of 
both transfected pELNIH (1.8-kb) and retrotransposed ELNIH (0.8-kb, Fig. 20). This 
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suggests that the vast majority of detected integration sites are a result of retrotransposed 
ELNIH but not from the integration of transfected episomal pELNIH vector. Of note, a band 
less than 0.9-kb was also detected by the PTK probe. This small band may indicate an low 
level of alternative splicing event of IVS sequence that results in a defective neo gene and 
therefore can only be observed in some G418-resistant colonies with multiple integrations of 
retrotransposed ELNIH. 
Retrotransposltion of pELNIH vector requires gag-pol gene products. To test 
whether the G418 resistant foci after pELNIH transfection could be a result of other 
endogenous cellular RT enzyme activity, three mutants of MoMLV gag-pol region were 
constpjcted. pGP was conducted by deleting the envgene from pPAM3 helper virus. The 
first mutant (pAG) has a deletion of matrix protein and capsid protein ORFs from the gag 
region of pGP. The second mutant (pAP) contains a deletion of RT from pol region of pGP. 
The third mutant (pAl) contains a frame-shifted mutation in the integrase (IN) ORF of pGP 
(Fig. 3). These three mutants and pGP were co-transfected with pELNIH into NIH3T3 and 
selected with hygromycin. Hygromycin resistant populations derived from these transfected 
cells were then plated under G418 selection to determine retrotransposltion frequencies as 
before. We also co-transfected pAG, pAP and pELNIH together to determine if 
retrotransposltion occurs when capsid structural proteins and pol gene products are 
translated in trans. Hygromycin-resistant cells (3 X 10® to 5 X 10®) were plated in triplicate 
under G418 selection for retrotransposltion events. In three different experiments, 
retrotransposltion of pELNIH vector was only observed in cells transfected with pGP 
construct (about 23 events in 10® cells). No G418-resistant colonies were observed in 
NIH3T3 cells transfected with mutant constructs or the combination of pAG and pAP 
plasmids. These results suggest that the RT enzyme activity required for retrotransposltion 
of pELNIH originates from MoMLV Pri 80^®®""°' but not from other cellular sources. 
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Retrotransposition of vectors likely requires normal particle assembly for vectors to be 
packaged inside of these intracellular particles, since complementation experiment of pAG 
and pAP in the same ceil did not show detectable retrotransposition activity. 
Retrotransposition in VPC is vector specific. To study whether the observed RT 
enzyme activity of helper virus in these retroviral packaging ceils is specific to pELNIH 
vector, a plasmid, pJM101, containing a human LI element (L1.2) and the same neo-int 
cassette (7, 29) was used as an altemative retrotransposition assay in VPC. This pJM101 is 
selectable with hygromycin and can replicate in the nucleus extrachromosomally as our 
pELNIH vector. However, the LI element In pJMIOI is a non-LTR retrotransposon and 
encodes its own nucleic acid-binding protein and reverse transcriptase for functional 
retrotransposition (11,14). Retrotransposition activity of LI .2 element has been well 
demonstrated in human HeLa cells and mouse fibroblast cell line, LTK- cells (29). 
In two experiments, similar frequencies of G418-resistant foci were observed in 
PA317, PG13 and NIH3T3 cells transfected with pJMIOI (Table 2). Since no significant 
differences were observed in retrotransposition events between NIH3T3 and packaging 
cells, PA317 and PG13, we conclude that the retrotransposition of pJMIOI depends mostly 
on its own protein components and not helper virus present in PA317 and PG13 cells. 
Therefore, the high frequency of retrotransposition observed in PA317, PG13 and NIH3T3-
GP cells transfected with pELNIH is retroviral vector specific (Table 1). 
DISCUSSION 
In this study, the retrotransposition of retroviral vectors has been demonstrated in 
VPC. These retrotransposition events required the presence of helper virus gag-pol gene 
products and are vector specific. Retrotransposed vectors can integrate into different 
chromosomal locations within one cell. The fi-equencies of vector retrotransposition inside 
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VPC are approximately 100-fold lower than vector superinfection, however, demonstration 
of retroti^ nsposition inside VPC may imply that RCR could develop firom recombination from 
vector and occasionally co-packaged helper virus transcripts within intracellular particles. 
To distinguish endogenous RT (derived from gag-pol precursor protein) from 
exogenous RT (mature RT activity imported by superinfection) inside of a virus-infected cell 
has practical difficulties. However, by comparing retrotransposition activity in PG13 and 
NIH3T3-GP to the total RT activity in PA317 cells, the percentage of endogenous RT activity 
that caused retrotransposition was estimated at 0.2% in PG13 and 7.8% in NIH3T3-GP 
cells. The increase of percentage in NIH3T3-GP is significant and may reflect more 
intracellular particles retained inside of cells compared to PG13 cells. If s important to note 
that NIH3T3-GP is a population of cells and not an individual cell clone like PG13. 
Therefore, we anticipate that the endogenous RT enzyme activity in NIH3T3-GP cells 
should be greater in an NIH3T3-GP clone with high gene expression. The elevation of RT 
enzyme activity in NIH3T3-GP cells will be expected to enhance effects of Env-Gag 
interaction on the reduction of vector retrotransposition. 
How Env-Gag interaction might affect retrotransposition of retroviral vectors needs 
more detailed study. This question is interesting since assembly and release of a virion 
particle does not require Env protein (reviewed in reference 15). However, Gag-Env 
Interaction has been observed in dorsal root ganglion (DRG) cells expressing both Gag and 
Env proteins of MoMLV and HIV respectively. Gag proteins were found to be co-localized 
with Env proteins in the somatic region of DRG cells and not scattered within entire DRG 
cell. Apparently, this interaction is specific and therefore was not observed from the 
heterologous pairs of Env and Gag proteins from HIV and MoMLV (42). HIV gp41 also has 
been reported to induce polarized budding of HIV from MDCK cells (21). These 
observations suggested that Env-Gag Interaction might attract assembling or assembled 
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virion particles with viral genome transcripts toward the cellular membrane and reduce the 
level of virion particles within the cells. Such a theory could explain our observation of 
reduced retrotransposition in PG13 cells compared to NIH3T3-GP cells. Although the 
demonstration of interaction between GaLV Env proteins and Gag proteins from MoMLV 
construct was not conducted in this study, several prior studies have indicated a possible 
interaction between GaLV Env and MLV Gag proteins. First, GaLV was originally transmitted 
to primates by rodents and not from a human retrovirus (20, 34). This is supported by the 
homology between GaLV and MLV in nucleic acid and protein sequences (1, 3) and an 
unusual degree of immunological cross-reactivity between the capsid proteins and RT of 
GaLVs and MLVs (37, 45). In gene transfer experiments, the packaging signals of both 
GaLV and MLV can be recognized by either GaLV or MLV core proteins (6). When GaLV 
Env protein is used to pseudotype MoMLV core particles in PG13 (27) and other cells (6, 
43), fairiy equivalent titers to PA317 are observed. In contrast, pseudotyping with HIV Env 
protein does not complement MoMLV core particles and produce infectious virions (43). 
Taken together, these studies indicate that GaLV Env protein can specifically interact with 
MoMLV Gag proteins. In this study, we also observed that this interaction might affect the 
frequency of vector retrotransposition. The outcomes of this study imply that an exogenous 
retrovirus can process Intracellular retrotransposition, a shortcut of replication cycle, In 
addition to cell-to cell infection. 
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TABLE 1. Retrotransposition frequencies of pELNIH 
vector in cultured VPC 
Experiment 
1 2 3 
PA317 423 X 10"^ 468X10"* 639X10"* 
PG13 1 XIO"^ 1 XIO"* 1 X 10"* 
NIH3T3-GP 48X10"^ 18X10"* 51 X10"* 
NIH3T3 <1 XIO"® <3X10"® < 1 X 10'® 
TABLE 2. Retrotransposition frequencies of fiuman 
LI retroelement (pJMIOI) in VPC 
Experiment 
1 2 
PA317 54X10"® 36X 10"® 
PG13 58 X 10"® 9X10"® 
NIH3T3 67X10"® 43X10"® 
FIG. 1. Retrotransposltion assay with pELNIH vector. (A) An overview of 
retrotransposition process of pELNIH vector. An indicator cassette containing an antisense 
copy of TK promoter (P) with the neo gene disrupted by intron 2 (IVS) of the y-globin gene 
was incorporated into pELNIH vector. The splicing donor (SD) and splicing acceptor (SA) of 
the intron (IVS) are indicated. A polyadenylation signal (A') is also in antisense orientation at 
3 end of neo gene. A hygromycin resistant gene (Hyg) is driven by both SV40 promoter 
(SV40) and a proi<aryotic promoter (indicated by an arrow). A prokaryotic replication origin 
(Ori) enables the cloning of integration sites of retrotransposed pELNIH. Transfected 
pELNIH could replicate extrachromosomally by a mammalian replication origin (OriP/EBNA 
1). Transcripts originating from 5 LTR can splice the intron, but contain an antisense copy of 
the neo gene. G418-resistant (G418'') colonies should arise only after this transcript is 
reverse transcribed into double-stranded DNA, integrated into chromosomes, and 
expressed by its own TK promoter (P). (B) Outline of retrotransposition assay. Hygromycin-
resistant (Hyg'') cell population was established on pELNIH-transfected cells and plated at 
different densities for G418 selection. G418-resistant foci represent retrotransposition 
events. 
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FIG. 2. Retrotransposed pELNIH vector integrated into different chromosomal 
locations. (A) Scheme of pELNIH and probes for detecting integrations of retrotransposed 
pELNiH and transfected pELNIH. After Sph[ digestion, a PTK probe (0.5-kb of Sal\/Sac\ 
fragment) detects a 1.9-kb fragment of transfected pELNIH with intron sequence and a 0.8-
kb fragment of retrotransposed pELNIH without intron. A Neo probe (0.35-kb of BamHUSpM 
fragment) detects 5 LTR with adjunct chromosomal DNA. (B) DNA extracted from G418-
resistant colonies isolated from PG13 transfected with pELNIH was digested with Sph\ and 
sequentially detected by either Neo probe or PTK probe on the same Southern blot 
membrane. Multiple bands on Neo probe detection represent multiple integrations at 
different chromosomal locations and copies of retrotransposed ELNIH in one cell were 
estimated from the multiple bands. These 1.9-kb and 0.8-kb bands are marked on Southern 
blot detected by PTK probe for transfected pELNIH and refrofransposed ELNIH vectors, 
respectively. A 1.4-kb band (indicated by "•") detected by PTK probe arises from the other 
TK promoter used for HStk selection marker gene in PG13, but is not seen in DNA extracted 
from NIH3T3-GP cells transfected with pELNIH (see panel C). A band smaller than 0.9-kb 
was detected on some of colonies and might originate from an alternative splicing of IVS 
intron. (C) DNA extracted from NH3T3-GP cells transfected with pELNIH was digested by 
SphI and sequentially detected by either Neo probe and PTK probe on the same Southern 
blot membrane. The integration of transfected pELNIH was only observed in one G418-
resistant colony. 
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FIG. 3. Scheme of serial deletion constaicts of MoMLV. These constaicts were 
carried by a modified pREP-10 (see Materials and Methods) and driven by RSV promoter 
and MoMLV 5 LTR. In pGP construct, env gene was deleted by AflWl restriction 
endonuclease and subcloned into modified pREP-10. Following deletion mutants are based 
on pGP. In pAG construct, MA and CA genes were deleted by Ami and Msc\ and then 
digestion sites were filled in to keep downstream ORFs in frame. In pAP, major portion of RT 
gene was deleted by Stu\ digestion without changing ORF of IN gene. In pAl construct, 
frame shifting of IN gene was conducted by insertion of two nucleotides into the C/al 
digestion site located at IN gene. 
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CHAPTER 6. GENERAL CONCLUSIONS 
Human gene transfer has been demonstrated to be feasible and can evoke biologic 
responses to human diseases. Most gene transfer clinical trials use retroviral vectors for the 
advantages of sustained vector production and integration of vectors. Although adverse 
events have been uncommon, safety considerations are an ever present concern. A risk 
associated with the use of retroviral vectors is the inadvertent generation of replication-
competent retroviruses (RCR) which may result from the recombination events between 
vector and the helper virus sequences present in packaging cell lines (1, 12, 15). The 
untoward effect of RCR is viremia (2) which in the long term can lead to neoplastic changes 
resulting from insertional mutagenesis (5). If s important to note that the integration of 
provirus is relatively stable and the mutagenesis caused by these events is a driving force of 
evolution. T-cell lymphoma has been observed in monkeys receiving bone marrow 
transplants intentionally infected with RCR (3, 15). Circulation of RCR from the blood stream 
into gonads may genetically alter germ cells, which allows RCR themselves with the 
mutations to be transmitted to generations. RCR can therefore be spread into human 
population by these individuals and may raise the risk of public health. 
Detection and prevention of RCR break-out has always been a major biosafety 
concern during preparation of retroviral vectors. Unfortunately, RCR occurs quite often and 
has been reported by several groups (1, 3, 12, 15) including our own. RCR originates from 
template switching between helper virus and vector transcripts. The template switching is 
caused by RT enzyme activity when a helper virus transcript is occasionally co-packaged 
into a virion particle with vector. The target cell for this potential RCR is the VPC itself in the 
cell culture or the human cells in vivo. VPC usually are not susceptible as a target for its own 
virus infection because the receptors on the VPC surface are supposedly occupied by viral 
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Env proteins on cell membrane thus preventing superinfection (Env-receptor interference). 
In this dissertation study, DNA methyiation was found to play an important role in 
superinfection of VPC by its own vector through inactivation of helper virus gene expression 
thereby reducing Env-receptor interference (Figure 1). The copy number of Integrated vector 
is also increased in VPC by superinfection and this causes variant genotypes in VPC 
population. The study of cell lineage in VPC cell culture initiated by continuous vector 
integration might be used to elucidate genome evolution of mammalian species by retrovirus 
infection. 
Is DNA methyiation activity increased specifically by intruding viral sequences or just 
a common phenomenon In a cell? In LTKOSN.2 VPC and Its subclones, DNA methyiation is 
only detected In helper virus sequences, but not vector. Furthermore, comparing the DNA 
methyiation status of the RT gene and the 5 LTR show a methyiation preference for the 
5 LTR over the RT region. However, the observations of DNA methyiation preference on 
helper virus over vector may be secondary to chromosomal locations. After a mixed 
population of VPC was established by using our chimeric retroviral helper virus (pAMS-
IRES-Zeo) and a vector, we examined the DNA methyiation status of both helper virus and 
vector. We did not observe significant differences of DNA methyiation between these two 
sequences. However, we should acknowledge that the method employed in this study is 
only detecting one or two restriction sites in approximately 8-kb of sequences and does not 
analyze DNA methyiation at all CpG islands on helper virus and vector. Several studies 
have indicated that DNA methyiation is a cellular defense system against retroelements (11, 
16, 17) and can be activated by viral infection (10). Serial deletion mutants of MoMLV 
constructed with IRES sequence and a selection marker will be useful to understand which 
region of MoMLV sequence Is responsible for the observed differences in DNA methyiation 
status between LTRs. 
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FIG. 1. Scheme of cascade reactions initiated by increased DNA methylation of helper virus 
5 LTR. DNA methylation inactivates helper virus gene expression and then vector 
production is reduced. Without sufficient Env-receptor interference, susceptibility to 
superinfection of vector from its own or other VPC in the same population is increased. 
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Since increased DNA metliylation leads to superinfection that nnight permit RCR 
formation, removing methylated helper virus from VPC populations should reduce RCR 
formation. A chimeric retroviral helper virus consisting of MoMLV helper virus, picomavirus 
IRES sequence and a selection marker gene was constructed and used to demonstrate that 
helper virus gene expression can be maintained through selection pressure with the cap-
independent translation mechanism of IRES sequence. Under continuous selection, 
superinfection was not detected in packaging cells established by using this chimeric helper 
virus. The potential use of this chimeric helper virus is to establish a packaging cell 
population from desired cell type without using a subcloning procedure. This is important 
while transplantation of VPC fn vivo is required for sustained gene transfer. Transplanted 
VPC need to evade host immune surveillance and therefore the best candidate for 
establishing VPC might be a primary cell culture from an individual to be treated. To 
demonstrate the usefulness of chimeric helper virus, we established a human packaging cell 
population from this helper virus and demonstrated that the vector packaged by human 
cells, but not by murine cells, is resistant to normal human serum that contains antibody 
against the a1-3 galactosyl epitopes on glycoproteins on non-primate cells (Appendix A). 
Superinfection assay on PA317 and LTKOSN.2 VPC demonstrated that only 0.2% to 
0.4% of population of PA317 and LTKOSN.2 VPC are susceptible to superinfection. These 
cells were exposed to GFP-expression vector only once in the experiment and do not 
represent culture conditions of VPC. An intron-containing vector used to detect 
retrotransposrtion activities in VPC is a very useful tool to determine superinfection in cell 
culture. The results show that about 10% of PA317 population is susceptible to 
superinfection when PA317 cells are consistently exposed to their own vectors. In addition 
to the RT enzyme activities imported by superinfection, intracellular virion particles also 
exhibit RT enzyme activity at a level equal to 7.8% of RT enzyme activity detected in 
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matured virions. The detection of RT enzyme activity in VPC with the evidence of vector 
retrotransposition poses a risk that RCR might occur from an intracellular virion particle 
instead of superinfection. The cause of RCR from retrotransposition events compared to 
superinfection events should be proportional to the ratio of endogenous RT enzyme activity. 
MoMLV is classified in the category of exogenous type C retrovirus which does not 
exhibit retrotransposition during their replication cycle (8). Retrotransposition has only been 
observed in an Env-defective MoMLV (14). With the presence of GaLV Env protein in PG13 
packaging cells, we found that MoMLV can process retrotransposition as a retrotransposon 
albeit at lower frequency (one log reduction). This provokes a possibility that exogenous 
retroviruses also use the retrotransposition route for replication as their ancestors do (Figure 
2). Formation of particle-like structures of HIV in the cytoplasm without detectable 
extracellular release of viral particles has been observed after deletion of the N-terminal 15 
amino acids of the MA protein (13). Observed retrotransposition of retrovirus might be 
resulted from intracellular budding of virion particles into cellular vacuoles (4, 9) caused by 
either mutations in matrix protein (4) or defective, unprocessed Env proteins (9). Therefore, 
the high frequency of retrotransposition observed in this study may partially be contributed 
by the errors arising from translation of Gag proteins. 
Taken together, an improved packaging cell line for human gene transfer should be 
based on a human cell line, have a selectable helper virus to eliminate host DNA 
methylation for high gene expression and vector production, and would package a 
xenotropic vector that does not superinfect its own VPC. A helper virus with regulated RT 
will be necessary to prevent RCR formation from intracellular retrotransposition of viral 
sequences. Mutagenesis of RT to generate a temperature-sensitive (ts) mutant (7) will 
permit the regulation of RT enzyme activity within a VPC. An HIV variant with a temperature-
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FIG. 2. Alternative pathway of retroviral replication. A viral particle can retain inside host cell 
and reverse transcribe its RNA genome into double-stranded DNA (provirus DNA) for 
integration without being budded off host cell. This process enables retrovirus to amplify its 
copy number intracellularly as observed with other retroelements. 
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sensitive RT mutant (6) has been constaicted and can replicate at 34.5°C but not 39.5°C. 
With the same theory, a (ts) mutant of RT can therefore be constructed to be active in 37°C 
for in vivo gene transfer and inactive in higher or lower temperatures for in vitro cell culture 
and vector production. A VPC containing a (ts) RT mutant should be useful for safer gene 
transfer application and viral replication study. 
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APPENDIX A. HUMAN RETROVIRAL PACKAGING CELLS BASED ON A 
CHIMERIC HELPER VIRUS FOR HIGH VECTOR PRODUCTION 
Won-Bin Young and Charles J. Link, Jr. 
The inhibition of the infectivity of murine type C retrovirus by human serum is 
mediated by human complement against a carbohydrate epitope from other mammals (3). 
This epitope is synthesized by an enzyme, a-(1,3)gaiactosyltransferase. The gene encoding 
this enzyme in human is a firameshifted mutant, therefore, human cells do not express this 
carbohydrate epitope (1). Pre-existing humoral immunity in humans recognize this epitope 
as a foreign antigen and neutralize invading micro-organisms such as bacteria and viruses. 
Retroviral vectors packaged by murine cells express those epitopes on their envelope 
proteins, which are susceptible to human serum inactivation. After being exposed to human 
serum, vector titer could therefore be reduced more than 90% (2). In contrast, retroviral 
vectors packaged from human cells are resistant to inactivation by human complement and 
human serum. We have established a population of human packaging cells, 293AM, by 
transfection of a chimeric retroviral helper virus, pAM3-IRES-Zeo (Chapter 4), into human 
embryonic kidney 293 cell line. Vectors packaged by 293AM cells were resistant to human 
serum inactivation (Fig. 1) and should increase the efficiency of gene transfer in human 
subjects. 
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FIG. 1. Variable sensitivity to human serum of vectors produced from different 
packaging cells. Vectors produced from murine AMIZ cells (A), and human 293AM cells (B) 
were examined. Surviving titers of G418-resistant colonies after incubation with fresh human 
serum and heat-inactivated human serum or culture medium at 37 °C for 40 min were 
measured. Relative titers for normal and heat-inactivated human serum treatment versus 
medium treatment are shown. Titers for medium treatments on human A375 cells were 2.5 
X 10® cfu/ml (293AM cells) and 2 X10® cfu/ml (AMIZ cells); on human IGROV cells were 5 
XIO'' (293AM cells) and 3.5 X 10® (AMIZ cells). 
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